| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | chromatin binding | NCOA3 NCOA6 STAG1 ARID1A AHDC1 RXRA CIC ARID5A TRIM66 TNRC18 TOX4 SUPT6H NFIX FOXO4 TSHZ3 IKZF3 ATF5 RBL2 NUP98 CBFA2T3 SKIL JMJD1C SBNO1 MCM9 | 2.33e-06 | 739 | 220 | 24 | GO:0003682 |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 6.89e-06 | 25 | 220 | 5 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.03e-05 | 27 | 220 | 5 | GO:0008139 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | BCL9L NCOA3 NCOA6 PPRC1 BCORL1 SERTAD2 BLNK ARID1A SPATA2 ARID5A KMT2C NPAT FOXP3 BICD2 ANK2 DTL NUP98 TOPBP1 NLRP1 CBFA2T3 JMJD1C SPTBN4 GAS2L1 KMT2D SHANK2 CBFA2T2 DOT1L SPEN HYAL2 NOS1AP | 1.19e-05 | 1160 | 220 | 30 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | BCL9L NCOA3 NCOA6 PPRC1 BCORL1 SERTAD2 ARID1A ARID5A KMT2C NPAT FOXP3 NUP98 CBFA2T3 JMJD1C KMT2D CBFA2T2 DOT1L SPEN HYAL2 | 1.59e-05 | 562 | 220 | 19 | GO:0003712 |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 3.33e-05 | 34 | 220 | 5 | GO:0046966 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | BCL9L NCOA3 NCOA6 PPRC1 BCORL1 SERTAD2 BLNK ARID1A SPATA2 AHDC1 ARID5A KMT2C NPAT FOXP3 BICD2 ANK2 DTL NUP98 TOPBP1 NLRP1 CBFA2T3 JMJD1C SPTBN4 GAS2L1 KMT2D SHANK2 CBFA2T2 DOT1L SPEN HYAL2 NOS1AP | 8.84e-05 | 1356 | 220 | 31 | GO:0060090 |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.28e-04 | 24 | 220 | 4 | GO:0008093 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | BCL9L NCOA3 NCOA6 PPRC1 SERTAD2 ARID1A KMT2C NPAT NUP98 KMT2D DOT1L HYAL2 | 1.43e-04 | 303 | 220 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | signal sequence binding | 2.41e-04 | 51 | 220 | 5 | GO:0005048 | |
| Domain | DUF4683 | 1.66e-06 | 3 | 222 | 3 | PF15735 | |
| Domain | DUF4683 | 1.66e-06 | 3 | 222 | 3 | IPR032757 | |
| Domain | LRRC37AB_C | 6.57e-06 | 4 | 222 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 6.57e-06 | 4 | 222 | 3 | PF14914 | |
| Domain | LRRC37_N | 6.57e-06 | 4 | 222 | 3 | IPR032754 | |
| Domain | LRRC37 | 6.57e-06 | 4 | 222 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 6.57e-06 | 4 | 222 | 3 | IPR015753 | |
| Domain | C8 | 3.37e-04 | 12 | 222 | 3 | PF08742 | |
| Domain | TIL | 3.37e-04 | 12 | 222 | 3 | PF01826 | |
| Domain | NHR2 | 4.19e-04 | 3 | 222 | 2 | PF08788 | |
| Domain | TAU_MAP_2 | 4.19e-04 | 3 | 222 | 2 | PS51491 | |
| Domain | Tubulin-binding | 4.19e-04 | 3 | 222 | 2 | PF00418 | |
| Domain | Teashirt_fam | 4.19e-04 | 3 | 222 | 2 | IPR027008 | |
| Domain | MAP_tubulin-bd_rpt | 4.19e-04 | 3 | 222 | 2 | IPR001084 | |
| Domain | CBFA2T1/2/3 | 4.19e-04 | 3 | 222 | 2 | IPR013289 | |
| Domain | NHR2 | 4.19e-04 | 3 | 222 | 2 | IPR014896 | |
| Domain | TAU_MAP_1 | 4.19e-04 | 3 | 222 | 2 | PS00229 | |
| Domain | MAP2/MAP4/Tau | 4.19e-04 | 3 | 222 | 2 | IPR027324 | |
| Domain | Unchr_dom_Cys-rich | 4.34e-04 | 13 | 222 | 3 | IPR014853 | |
| Domain | C8 | 4.34e-04 | 13 | 222 | 3 | SM00832 | |
| Domain | TIL_dom | 5.47e-04 | 14 | 222 | 3 | IPR002919 | |
| Domain | Post-SET_dom | 8.28e-04 | 16 | 222 | 3 | IPR003616 | |
| Domain | PostSET | 8.28e-04 | 16 | 222 | 3 | SM00508 | |
| Domain | VWF_type-D | 8.28e-04 | 16 | 222 | 3 | IPR001846 | |
| Domain | VWFD | 8.28e-04 | 16 | 222 | 3 | PS51233 | |
| Domain | AT_hook | 8.28e-04 | 16 | 222 | 3 | PF02178 | |
| Domain | VWD | 8.28e-04 | 16 | 222 | 3 | SM00216 | |
| Domain | POST_SET | 8.28e-04 | 16 | 222 | 3 | PS50868 | |
| Domain | VWD | 8.28e-04 | 16 | 222 | 3 | PF00094 | |
| Domain | CH | 1.05e-03 | 65 | 222 | 5 | SM00033 | |
| Domain | G_crystallin-rel | 1.18e-03 | 18 | 222 | 3 | IPR011024 | |
| Domain | FYrich_C | 1.37e-03 | 5 | 222 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.37e-03 | 5 | 222 | 2 | IPR003888 | |
| Domain | FYRC | 1.37e-03 | 5 | 222 | 2 | SM00542 | |
| Domain | FYRN | 1.37e-03 | 5 | 222 | 2 | SM00541 | |
| Domain | TAFH | 1.37e-03 | 5 | 222 | 2 | SM00549 | |
| Domain | TAFH_NHR1 | 1.37e-03 | 5 | 222 | 2 | IPR003894 | |
| Domain | TAFH | 1.37e-03 | 5 | 222 | 2 | PS51119 | |
| Domain | FYRN | 1.37e-03 | 5 | 222 | 2 | PF05964 | |
| Domain | FYRC | 1.37e-03 | 5 | 222 | 2 | PF05965 | |
| Domain | FYRC | 1.37e-03 | 5 | 222 | 2 | PS51543 | |
| Domain | FYRN | 1.37e-03 | 5 | 222 | 2 | PS51542 | |
| Domain | TAFH | 1.37e-03 | 5 | 222 | 2 | PF07531 | |
| Domain | VWC_out | 1.39e-03 | 19 | 222 | 3 | SM00215 | |
| Domain | Pyr_redox_2 | 1.39e-03 | 19 | 222 | 3 | PF07992 | |
| Domain | CH | 1.47e-03 | 70 | 222 | 5 | PF00307 | |
| Domain | - | 1.56e-03 | 71 | 222 | 5 | 1.10.418.10 | |
| Domain | CH | 1.77e-03 | 73 | 222 | 5 | PS50021 | |
| Domain | PHD | 1.99e-03 | 75 | 222 | 5 | PF00628 | |
| Domain | CH-domain | 1.99e-03 | 75 | 222 | 5 | IPR001715 | |
| Domain | SPOC_C | 2.04e-03 | 6 | 222 | 2 | IPR012921 | |
| Domain | GAR | 2.04e-03 | 6 | 222 | 2 | PS51460 | |
| Domain | GAS2 | 2.04e-03 | 6 | 222 | 2 | PF02187 | |
| Domain | - | 2.04e-03 | 6 | 222 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 2.04e-03 | 6 | 222 | 2 | IPR003108 | |
| Domain | SPOC | 2.04e-03 | 6 | 222 | 2 | PF07744 | |
| Domain | GAS2 | 2.04e-03 | 6 | 222 | 2 | SM00243 | |
| Domain | TF_fork_head_CS_2 | 2.14e-03 | 46 | 222 | 4 | IPR030456 | |
| Domain | EPHD | 2.16e-03 | 22 | 222 | 3 | PS51805 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.15e-05 | 68 | 160 | 7 | M27303 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 8.45e-05 | 40 | 160 | 5 | MM14945 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 9.25e-05 | 65 | 160 | 6 | M39682 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.25e-04 | 143 | 160 | 8 | M27275 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.25e-04 | 49 | 160 | 5 | MM14837 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.41e-04 | 109 | 160 | 7 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.69e-04 | 111 | 160 | 7 | M27416 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.73e-04 | 51 | 160 | 5 | MM15151 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.04e-04 | 29 | 160 | 4 | M48076 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP2 MAP4 TSHZ2 MBNL1 BLNK U2AF2 MGLL SYNPO ARID1A SSPOP AHDC1 RXRA TASOR2 SHKBP1 KMT2C TNRC18 SUPT6H NFIX OSBPL9 NAV1 C1orf159 RPRD2 ARHGAP8 ANKS1A CARMIL1 CHCHD6 IQCN PRKRIP1 JMJD1C KANSL3 SPTBN4 THAP4 SHANK2 MICAL2 KIAA1217 CBFA2T2 MACF1 TNK2 ZFHX3 CEP170B NLK | 8.16e-15 | 1489 | 230 | 41 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SYNRG NCOA6 MAP2 MAP4 ARHGEF17 CIC SHKBP1 CDCA2 NAV1 FOXO4 PLEKHA7 FOXK1 ANKS1A TTC28 CARMIL1 COBLL1 SH3GL1 DTL E2F8 NHSL1 MEGF8 KIAA1217 PHACTR4 FMN2 MACF1 R3HDM1 SRRM2 CEP170B MAP3K2 NOS1AP OTOG | 2.13e-14 | 861 | 230 | 31 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RNF223 SYNRG NCOA6 REPS1 PPRC1 THAP8 ARID1A ARHGEF11 BIRC6 TNFRSF21 AHDC1 CIC JAK3 KMT2C TNRC18 NAV1 MMP14 FOXK1 CRYBG2 NUP214 PRKRIP1 REV3L KANSL3 NHSL1 GAS2L1 KMT2D SHANK2 MEGF8 CSPG4 LRP4 TNK2 DOT1L SPEN CEP170B | 9.55e-14 | 1105 | 230 | 34 | 35748872 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 BCORL1 GMEB2 ARID1A CDCA2 KMT2C TNRC18 NFIX FOXK1 TSHZ3 RBL2 NLRP1 JMJD1C CCNB1 KMT2D ZFHX4 ZNF518B DOT1L MYO15A RAI2 | 3.11e-12 | 398 | 230 | 20 | 35016035 |
| Pubmed | BCL9L NCOA3 NCOA6 ETV3 ARID1A AHDC1 CIC CDCA2 TNRC18 NFIX RPRD2 FOXK1 SKIL JMJD1C KANSL3 KMT2D IK | 3.58e-12 | 268 | 230 | 17 | 33640491 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | NCOA3 GCM2 TSHZ2 THAP8 ETV3 GMEB2 RXRA CIC TOX4 NFIX FOXO4 ZNF282 FOXK1 FOXP3 FOXM1 TSHZ3 IKZF3 ATF5 ETV7 SKIL RFX4 ATF6B E2F8 THAP4 KMT2D ZSCAN20 ZFHX4 ZFHX3 | 1.67e-11 | 908 | 230 | 28 | 19274049 |
| Pubmed | SYNRG NCOA6 REPS1 MAP4 ACLY TNIP1 ARID1A KMT2C TOX4 OSBPL9 RPRD2 TTC28 SH3GL1 DIDO1 SPECC1L JMJD1C SETD2 KMT2D PHACTR4 DOT1L IK SPEN | 2.07e-11 | 549 | 230 | 22 | 38280479 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SYNRG BCORL1 TNIP1 ARID1A CIC SUPT6H NAV1 FOXK1 FOXM1 BICD2 IKZF3 TTC28 DTL TOPBP1 RUFY3 KANSL3 SETD2 KIAA1217 MACF1 DOT1L SPEN CEP170B | 7.71e-11 | 588 | 230 | 22 | 38580884 |
| Pubmed | BCL9L NCOA3 NCOA6 MBNL1 BCORL1 ETV3 TNIP1 GMEB2 ARID1A SPATA2 RXRA CIC CDCA2 KMT2C NFIX RPRD2 FOXK1 NPAT TSHZ3 IKZF3 ETV7 NUP98 DIDO1 NUP214 JMJD1C KANSL3 KMT2D ZFHX4 ZFHX3 DOT1L R3HDM1 SRRM2 SPEN RAI2 | 1.08e-10 | 1429 | 230 | 34 | 35140242 | |
| Pubmed | U2AF2 TNIP1 GMEB2 SSPOP AHDC1 CIC ARID5A TOX4 POM121 KIAA1549L SACS SPAG5 TDRD7 SETD2 MEGF8 USHBP1 CBFA2T2 ROBO2 R3HDM1 SPEN NLK RAI2 | 1.45e-10 | 608 | 230 | 22 | 16713569 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA3 NCOA6 BCORL1 ARID1A AHDC1 KMT2C TNRC18 FOXK1 TSHZ3 DTL NUP98 NUP214 KMT2D ZFHX4 ZFHX3 SPEN | 2.46e-10 | 351 | 230 | 17 | 38297188 |
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | MAP4 DAG1 SYNPO ASAP1 SHKBP1 POM121 CARMIL1 GAS2L1 PHACTR4 SRRM2 | 2.89e-09 | 108 | 230 | 10 | 19531213 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | BCL9L NCOA3 MBNL1 ETV3 DAG1 ARHGEF11 NFIX RPRD2 PLEKHA7 NUP98 JMJD1C R3HDM1 | 3.28e-09 | 180 | 230 | 12 | 35198878 |
| Pubmed | NCOA3 BCORL1 TNIP1 BIRC6 CIC TOX4 NAV1 NPAT BICD2 TSHZ3 TTC28 NUP214 JMJD1C SPAG5 KMT2D ZFHX4 ZFHX3 | 3.46e-09 | 418 | 230 | 17 | 34709266 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 CIC ASAP1 TASOR2 TNRC18 POM121 PLEKHA7 TSHZ3 ATF5 NUP98 NUP214 SH3D21 CBFA2T2 TNK2 SPEN SDCBP2 SON | 5.27e-09 | 430 | 230 | 17 | 35044719 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 BCORL1 U2AF2 ARID1A SQOR AHDC1 CIC DHX8 CDCA2 KMT2C TOX4 SUPT6H NFIX RPRD2 FOXK1 NUP98 TOPBP1 DIDO1 NUP214 SKIL JMJD1C KANSL3 THAP4 SETD2 KMT2D IK SRRM2 SPEN SON | 1.09e-08 | 1294 | 230 | 29 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 SYNRG NCOA6 MAP4 ACLY CIC ANKS1A FOXM1 BICD2 CARMIL1 NUP98 DIDO1 NUP214 IQCN KANSL3 SETD2 KMT2D CBFA2T2 PHACTR4 SRRM2 SPEN SON | 1.22e-08 | 774 | 230 | 22 | 15302935 |
| Pubmed | MAP2 MAP4 SLC6A17 SYNPO ELFN2 KCNB1 SACS SGIP1 ANK2 SHANK2 FMN2 MACF1 SRRM2 CEP170B NLK | 1.32e-08 | 347 | 230 | 15 | 17114649 | |
| Pubmed | PPRC1 SPATA2 ARHGEF17 ASAP1 NAV1 BICD2 TTC28 NUP214 MEGF8 MACF1 R3HDM1 SRRM2 SPEN CEP170B NOS1AP SON | 1.63e-08 | 407 | 230 | 16 | 12693553 | |
| Pubmed | BCL9L NCOA3 ARID1A BIRC6 AHDC1 TASOR2 KMT2C SUPT6H CRYBG1 ANKS1A CRYBG2 TTC28 NUP98 NUP214 CCNB1 KMT2D SPEN | 1.89e-08 | 469 | 230 | 17 | 27634302 | |
| Pubmed | MAP2 MAP4 ACLY SYNPO ARID1A ARHGEF11 ARHGEF17 ELFN2 ASAP1 SACS OSBPL9 NAV1 MAP7D2 PLEKHA7 SGIP1 ANK2 ARHGAP23 PRR36 CARMIL1 SH3GL1 SPECC1L RUFY3 SPTBN4 NHSL1 GAS2L1 SHANK2 MICAL2 KIAA1217 MACF1 CEP170B | 2.65e-08 | 1431 | 230 | 30 | 37142655 | |
| Pubmed | SYNPO ARHGEF11 CIC ASAP1 KMT2C TOX4 POM121 KIAA1549L NAV1 COBLL1 NUP98 NUP214 SPECC1L LCP2 MACF1 TNK2 MAP3K2 | 3.16e-08 | 486 | 230 | 17 | 20936779 | |
| Pubmed | TNIP1 BIRC6 ELFN2 TRIM66 TNRC18 TOX4 POM121 SACS ARHGAP25 ARHGAP23 COBLL1 JMJD1C SETD2 MACF1 ZNF518B POM121B PDZRN3 | 3.89e-08 | 493 | 230 | 17 | 15368895 | |
| Pubmed | 8.34e-08 | 83 | 230 | 8 | 28794006 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 INCENP MAP4 MBNL1 BCORL1 U2AF2 ARID1A CIC TASOR2 CDCA2 TOX4 RPRD2 NPAT NUP98 TOPBP1 DIDO1 NUP214 JMJD1C SETD2 IK SRRM2 SPEN SON | 1.12e-07 | 954 | 230 | 23 | 36373674 |
| Pubmed | NCOA6 REPS1 STAG1 INCENP ARID1A CIC ASAP1 DHX8 OSBPL9 RPRD2 DIDO1 SPAG5 KANSL3 MACF1 IK SRRM2 | 1.24e-07 | 472 | 230 | 16 | 38943005 | |
| Pubmed | BCL9L SYNRG EMC3 MAP2 MAP4 DAG1 SYNPO BIRC6 ELFN2 ASAP1 TNRC18 KCNB1 NAV1 MAP7D2 BICD2 SGIP1 ANK2 SH3GL1 RUFY3 NHSL1 SHANK2 KIAA1217 MACF1 CEP170B NOS1AP | 1.80e-07 | 1139 | 230 | 25 | 36417873 | |
| Pubmed | 2.28e-07 | 130 | 230 | 9 | 12421765 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | STAG1 ACLY TNIP1 RXRA CIC NFIX FOXO4 FOXK1 FOXP3 FOXM1 RBL2 NUP98 REV3L CBFA2T3 SKIL JMJD1C KANSL3 KMT2D ZFHX4 CBFA2T2 SPEN | 3.14e-07 | 857 | 230 | 21 | 25609649 |
| Pubmed | NCOA3 NCOA6 MAP4 ACLY MBNL1 BCORL1 GMEB2 ARID1A AHDC1 CIC KMT2C TNRC18 FOXK1 DIDO1 PRKRIP1 JMJD1C E2F8 CCNB1 KANSL3 THAP4 KMT2D IK SRRM2 SPEN | 3.76e-07 | 1103 | 230 | 24 | 34189442 | |
| Pubmed | 1.14e-06 | 4 | 230 | 3 | 34645806 | ||
| Pubmed | 1.14e-06 | 4 | 230 | 3 | 22419166 | ||
| Pubmed | MYLK STAG1 PPRC1 U2AF2 GOLGA6B SYNPO ARID1A TASOR2 CDCA2 TNRC18 SACS MAP7D2 METTL25 ITIH6 ANK2 DTL NUP98 RNF17 SH3D21 ADAMTS12 SPTBN4 SHANK2 SBNO1 CSPG4 MACF1 SPEN MYBPC1 | 1.25e-06 | 1442 | 230 | 27 | 35575683 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MAP4 DAG1 ELFN2 ASAP1 CRYBG1 PLEKHA7 ARHGAP23 CARMIL1 COBLL1 SH3GL1 NUP214 NHSL1 SHANK2 KIAA1217 PHACTR4 MACF1 | 1.34e-06 | 565 | 230 | 16 | 25468996 |
| Pubmed | BRPF3 U2AF2 ARID1A SQOR TRIM66 TARBP2 FOXK1 GPBAR1 TTC28 ARHGAP23 REV3L SKIL SETD2 ZFHX4 LRP4 FMN2 MACF1 ZFHX3 SRRM2 PDZRN3 CEP170B NOS1AP SON | 1.67e-06 | 1116 | 230 | 23 | 31753913 | |
| Pubmed | INCENP MAP4 ACLY U2AF2 ARID1A BIRC6 TASOR2 DHX8 SUPT6H NUP98 DIDO1 NUP214 MACF1 IK SRRM2 SPEN SON | 1.95e-06 | 653 | 230 | 17 | 22586326 | |
| Pubmed | NCOA3 BNC2 GCM2 MBNL1 SERTAD2 ETV3 ARID1A RXRA CIC TOX4 ZNF282 FOXK1 FOXM1 DIDO1 SKIL ATF6B THAP4 ZSCAN20 ZFHX3 | 2.14e-06 | 808 | 230 | 19 | 20412781 | |
| Pubmed | BCL9L ARID1A AHDC1 TNRC18 TOX4 SACS NAV1 MAP7D2 FOXK1 MACF1 ZNF518B SON | 2.51e-06 | 332 | 230 | 12 | 37433992 | |
| Pubmed | BCL9L REPS1 MAP4 ARHGEF11 SQOR AHDC1 CIC DHX8 SHKBP1 KMT2C SUPT6H CRYBG1 PLEKHA7 TARBP2 FOXK1 TOPBP1 DIDO1 SPECC1L CEP164 SETD2 SHANK2 MACF1 ZFHX3 IK SPEN CEP170B SON | 2.52e-06 | 1497 | 230 | 27 | 31527615 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | BCL9L NCOA3 NCOA6 MBNL1 ARID1A AHDC1 CIC KMT2C POM121 FOXK1 NUP98 NUP214 JMJD1C KMT2D | 2.54e-06 | 457 | 230 | 14 | 32344865 |
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 2.63e-06 | 130 | 230 | 8 | 35545047 | |
| Pubmed | NCOA6 BRPF3 SERTAD2 SYNPO GMEB2 KMT2C SUPT6H RPRD2 ANKS1A TOPBP1 DIDO1 RUFY3 KANSL3 LRP4 ROBO2 | 2.85e-06 | 529 | 230 | 15 | 14621295 | |
| Pubmed | BCORL1 U2AF2 CDCA2 TOX4 RPRD2 NPAT FOXM1 DIDO1 JMJD1C SBNO1 IK SPEN | 3.11e-06 | 339 | 230 | 12 | 30415952 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.31e-06 | 283 | 230 | 11 | 30585729 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | STAG1 INCENP BCORL1 SYNPO CIC DHX8 CDCA2 FOXK1 NPAT TSHZ3 TOPBP1 DIDO1 JMJD1C SBNO1 DOT1L SPEN | 3.43e-06 | 608 | 230 | 16 | 36089195 |
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 3.89e-06 | 63 | 230 | 6 | 29162697 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 4.15e-06 | 184 | 230 | 9 | 32908313 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | SYNRG UBAP1 SPATA2 ARHGEF11 ASAP1 MAP7D2 PLEKHA7 ANKS1A BICD2 TTC28 TROAP CARMIL1 SH3GL1 CEP164 SPAG5 KIAA1217 PHACTR4 PDZRN3 CEP170B | 4.67e-06 | 853 | 230 | 19 | 28718761 |
| Pubmed | REPS1 STAG1 PPRC1 SYNPO ARID1A DSCAML1 TRIM66 SACS BICD2 ANK2 TTC28 RBL2 REV3L SKIL SEC31B RUFY3 SPTBN4 THAP4 SBNO1 MICAL2 LRP4 FMN2 MACF1 R3HDM1 | 5.29e-06 | 1285 | 230 | 24 | 35914814 | |
| Pubmed | 5.47e-06 | 102 | 230 | 7 | 19741146 | ||
| Pubmed | Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. | 5.63e-06 | 6 | 230 | 3 | 17021013 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ACLY TNIP1 SYNPO TASOR2 KIAA1549L RPRD2 ANKRD40 SPAG5 TDRD7 SPTBN4 SETD2 MEGF8 IK R3HDM1 RAI2 | 5.65e-06 | 560 | 230 | 15 | 21653829 |
| Pubmed | 5.84e-06 | 103 | 230 | 7 | 10574462 | ||
| Pubmed | BCL9L NCOA3 NCOA6 INCENP BCORL1 ETV3 U2AF2 GMEB2 ARID1A CIC CDCA2 SH3GL1 R3HDM1 | 5.91e-06 | 425 | 230 | 13 | 24999758 | |
| Pubmed | 6.22e-06 | 104 | 230 | 7 | 9205841 | ||
| Pubmed | NCOA3 MAP4 TNIP1 RPRD2 BICD2 TROAP COBLL1 DTL NUP98 TOPBP1 DIDO1 SRRM2 SPEN SON | 7.58e-06 | 503 | 230 | 14 | 16964243 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 8.31e-06 | 20 | 230 | 4 | 29785026 | |
| Pubmed | 8.31e-06 | 20 | 230 | 4 | 19047629 | ||
| Pubmed | 9.80e-06 | 7 | 230 | 3 | 19556342 | ||
| Pubmed | ARID1A POM121 PLEKHA7 ANKS1A TTC28 SH3GL1 JMJD1C KIAA1217 MACF1 R3HDM1 | 1.13e-05 | 263 | 230 | 10 | 34702444 | |
| Pubmed | 1.13e-05 | 263 | 230 | 10 | 20932939 | ||
| Pubmed | 1.35e-05 | 78 | 230 | 6 | 28611094 | ||
| Pubmed | Acetoacetyl-CoA synthetase is essential for normal neuronal development. | 1.56e-05 | 8 | 230 | 3 | 23000407 | |
| Pubmed | CTU2 BCORL1 SYNPO DSCAML1 CIC KMT2C TNRC18 RPRD2 TARBP2 FOXK1 ICAM1 THAP4 NHSL1 USHBP1 ROBO2 OTOG | 1.62e-05 | 689 | 230 | 16 | 36543142 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG REPS1 MAP4 ACLY CIC TOX4 RPRD2 ANKS1A ANK2 CARMIL1 SH3GL1 NUP98 DIDO1 NUP214 SPAG5 SETD2 KIAA1217 MACF1 SON | 1.66e-05 | 934 | 230 | 19 | 33916271 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.74e-05 | 220 | 230 | 9 | 35785414 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.87e-05 | 123 | 230 | 7 | 26912792 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 STAG1 ARID1A TOX4 FOXK1 DIDO1 JMJD1C KMT2D SBNO1 SRRM2 SPEN | 1.91e-05 | 341 | 230 | 11 | 32971831 |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | NCOA6 MAP4 ARID1A ARID5A TRIM66 NUP98 NLRP1 NUP214 R3HDM1 SPEN | 2.11e-05 | 283 | 230 | 10 | 18854154 |
| Pubmed | 2.23e-05 | 227 | 230 | 9 | 26410627 | ||
| Pubmed | GCM2 MBNL1 SERTAD2 ARID1A BIRC6 RXRA CIC KMT2C TOX4 FOXO4 FOXK1 FOXM1 ATF5 DIDO1 MACF1 ZFHX3 | 2.30e-05 | 709 | 230 | 16 | 22988430 | |
| Pubmed | Endophilin-A2 dependent VEGFR2 endocytosis promotes sprouting angiogenesis. | 2.48e-05 | 26 | 230 | 4 | 31138815 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 2.56e-05 | 231 | 230 | 9 | 16452087 | |
| Pubmed | NCOA6 ACLY U2AF2 ARHGEF17 KIAA1549L COBLL1 KMT2D MACF1 SRRM2 | 2.84e-05 | 234 | 230 | 9 | 36243803 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SYNRG MAP4 ACLY MBNL1 U2AF2 DHX8 BICD2 SH3GL1 SPECC1L CCNB1 MACF1 IK R3HDM1 SPEN NOS1AP SON | 2.95e-05 | 724 | 230 | 16 | 36232890 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | SYNPO CDCA2 TOX4 SUPT6H NAV1 RPRD2 SPECC1L SPAG5 KIAA1217 SRRM2 SON | 3.21e-05 | 361 | 230 | 11 | 30344098 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L MAP4 DPYD DIDO1 JMJD1C SPTBN4 ZFHX4 MACF1 SRRM2 SPEN SON | 3.21e-05 | 361 | 230 | 11 | 26167880 |
| Pubmed | Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. | 3.31e-05 | 10 | 230 | 3 | 19413330 | |
| Pubmed | 3.31e-05 | 10 | 230 | 3 | 23064749 | ||
| Pubmed | 3.83e-05 | 57 | 230 | 5 | 18022353 | ||
| Pubmed | LGMN MAP4 PPRC1 MBNL1 DAG1 ASAP1 KMT2C CRYBG1 SUCO PLEKHA7 ANKRD40 NPAT DTL DIDO1 E2F8 SPAG5 FMN2 MACF1 DOT1L IK | 3.95e-05 | 1084 | 230 | 20 | 11544199 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 24714775 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 29705704 | ||
| Pubmed | Tumor-derived death receptor 6 modulates dendritic cell development. | 4.35e-05 | 2 | 230 | 2 | 17962943 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 28188290 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 31924266 | ||
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 4.35e-05 | 2 | 230 | 2 | 10873665 | |
| Pubmed | Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk. | 4.35e-05 | 2 | 230 | 2 | 25254322 | |
| Pubmed | m6Am methyltransferase PCIF1 negatively regulates ciliation by inhibiting BICD2 expression. | 4.35e-05 | 2 | 230 | 2 | 38526325 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 28967912 | ||
| Pubmed | The mitotic spindle protein SPAG5/Astrin connects to the Usher protein network postmitotically. | 4.35e-05 | 2 | 230 | 2 | 23351521 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 18454303 | ||
| Pubmed | BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. | 4.35e-05 | 2 | 230 | 2 | 19047679 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 17591781 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 36263184 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 36601880 | ||
| Pubmed | Two dimensional Blue Native-/SDS-PAGE analysis of SLP family adaptor protein complexes. | 4.35e-05 | 2 | 230 | 2 | 16356554 | |
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 28483418 | ||
| Pubmed | 4.35e-05 | 2 | 230 | 2 | 14694181 | ||
| Pubmed | Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. | 4.35e-05 | 2 | 230 | 2 | 7686164 | |
| Interaction | TLE3 interactions | BCL9L NCOA3 MBNL1 BCORL1 GMEB2 ARID1A AHDC1 CIC TNRC18 POM121 NFIX ANKRD40 TSHZ3 SPTBN4 SETD2 KMT2D ZFHX3 DOT1L SRRM2 SPEN NLK SON | 2.94e-10 | 376 | 226 | 22 | int:TLE3 |
| Interaction | NUP43 interactions | BCL9L NCOA6 INCENP MAP4 ARID1A AHDC1 TASOR2 DHX8 CDCA2 POM121 SUPT6H NPAT BICD2 NUP98 TOPBP1 NUP214 JMJD1C SPAG5 TDRD7 KANSL3 SETD2 KMT2D ZFHX3 SRRM2 SPEN SON | 9.64e-09 | 625 | 226 | 26 | int:NUP43 |
| Interaction | YWHAH interactions | LGMN NCOA3 SYNRG NCOA6 MAP2 ARHGEF17 CIC PYHIN1 SHKBP1 CDCA2 NAV1 FOXO4 SUCO PLEKHA7 FOXK1 ANKS1A TTC28 CARMIL1 COBLL1 SH3GL1 DTL SPECC1L E2F8 NHSL1 MEGF8 KIAA1217 PHACTR4 FMN2 MACF1 R3HDM1 SRRM2 CEP170B MAP3K2 NOS1AP OTOG | 2.42e-08 | 1102 | 226 | 35 | int:YWHAH |
| Interaction | PAX9 interactions | BCL9L NCOA3 NCOA6 MBNL1 ARID1A CIC KMT2C NFIX FOXK1 KMT2D ZFHX4 ZFHX3 | 2.66e-08 | 130 | 226 | 12 | int:PAX9 |
| Interaction | SOX7 interactions | NCOA3 BCORL1 ARID1A KMT2C TNRC18 JMJD1C KMT2D ZFHX4 ZNF518B DOT1L | 2.72e-08 | 82 | 226 | 10 | int:SOX7 |
| Interaction | PIN1 interactions | NCOA3 REPS1 INCENP U2AF2 TNIP1 GMEB2 ARID5A SHKBP1 SSC5D SUPT6H FOXO4 ANKRD40 BICD2 IKZF3 NUP98 DIDO1 CBFA2T3 CCNB1 SRRM2 | 7.13e-08 | 383 | 226 | 19 | int:PIN1 |
| Interaction | YWHAG interactions | SYNRG NCOA6 MAP2 SYNPO ARHGEF17 CIC PYHIN1 SHKBP1 CDCA2 NAV1 FOXO4 SUCO PLEKHA7 FOXK1 ANKS1A TTC28 ARHGAP23 CARMIL1 COBLL1 SH3GL1 DTL SPECC1L E2F8 NHSL1 PHACTR4 FMN2 MACF1 TNK2 R3HDM1 SRRM2 CEP170B MAP3K2 NOS1AP OTOG SON | 4.88e-07 | 1248 | 226 | 35 | int:YWHAG |
| Interaction | TBR1 interactions | 5.84e-07 | 113 | 226 | 10 | int:TBR1 | |
| Interaction | LHX2 interactions | BCL9L BCORL1 GMEB2 ARID1A CIC KMT2C FOXK1 ANKS1A TSHZ3 KMT2D ZFHX4 ZFHX3 | 1.12e-06 | 183 | 226 | 12 | int:LHX2 |
| Interaction | PAX7 interactions | 1.38e-06 | 124 | 226 | 10 | int:PAX7 | |
| Interaction | PHF21A interactions | BCORL1 TNIP1 BIRC6 CIC TOX4 NAV1 NPAT BICD2 TSHZ3 TTC28 NUP214 JMJD1C SPAG5 KMT2D ZFHX4 ZFHX3 | 1.78e-06 | 343 | 226 | 16 | int:PHF21A |
| Interaction | HDAC1 interactions | STAG1 U2AF2 TNIP1 ARID1A BIRC6 CIC TNRC18 TOX4 NFIX NAV1 FOXK1 NPAT FOXP3 BICD2 TSHZ3 IKZF3 TTC28 RBL2 NUP98 NUP214 CBFA2T3 SKIL JMJD1C SPAG5 CCNB1 KMT2D CCDC71 ZFHX4 ZFHX3 DOT1L SPEN | 2.50e-06 | 1108 | 226 | 31 | int:HDAC1 |
| Interaction | SH3KBP1 interactions | MAP4 GGN BLNK DAG1 SYNPO ASAP1 SHKBP1 TNRC18 POM121 ANKS1A CARMIL1 SH3GL1 GAS2L1 PHACTR4 SRRM2 | 2.93e-06 | 315 | 226 | 15 | int:SH3KBP1 |
| Interaction | EGR2 interactions | BCL9L NCOA3 NCOA6 BCORL1 ARID1A AHDC1 KMT2C TNRC18 KMT2D ZFHX4 ZFHX3 | 3.79e-06 | 171 | 226 | 11 | int:EGR2 |
| Interaction | MAPRE1 interactions | REPS1 MAP2 U2AF2 SYNPO IGSF10 NAV1 MAP7D2 BICD2 TROAP NUP98 NUP214 SPECC1L SPAG5 GAS2L1 KIAA1217 MACF1 SRRM2 POM121B CEP170B | 5.87e-06 | 514 | 226 | 19 | int:MAPRE1 |
| Interaction | GSC interactions | 6.03e-06 | 87 | 226 | 8 | int:GSC | |
| Interaction | CRX interactions | BCL9L NCOA3 GCM2 BCORL1 ARID1A KMT2C TNRC18 FOXK1 M1AP KMT2D ZFHX4 ZFHX3 SPEN | 6.27e-06 | 254 | 226 | 13 | int:CRX |
| Interaction | TBXT interactions | 6.45e-06 | 116 | 226 | 9 | int:TBXT | |
| Interaction | AR interactions | BCL9L NCOA3 NCOA6 ACLY BLNK ETV3 U2AF2 ARID1A AHDC1 CIC ARID5A CDCA2 KMT2C TNRC18 NFIX RPRD2 FOXK1 DIDO1 SKIL JMJD1C KANSL3 KMT2D KIAA1217 TNK2 ZFHX3 DOT1L IK SON | 6.82e-06 | 992 | 226 | 28 | int:AR |
| Interaction | MAPRE3 interactions | MAP2 MAP4 NAV1 MAP7D2 TTC28 TROAP SPECC1L SPAG5 GAS2L1 KIAA1217 MACF1 CEP170B | 1.18e-05 | 230 | 226 | 12 | int:MAPRE3 |
| Interaction | SOX9 interactions | 1.36e-05 | 97 | 226 | 8 | int:SOX9 | |
| Interaction | TERF2IP interactions | NCOA6 INCENP GMEB2 ARID1A CIC TASOR2 DHX8 CDCA2 SUPT6H NPAT TOPBP1 DIDO1 KANSL3 SETD2 SBNO1 HAAO IK SRRM2 SPEN | 1.60e-05 | 552 | 226 | 19 | int:TERF2IP |
| Interaction | GSK3A interactions | SYNRG MAP2 LRRC37A2 U2AF2 ARHGEF11 AHDC1 TNRC18 CRYBG1 ANKS1A FOXM1 TTC28 SPAG5 NHSL1 SBNO1 MACF1 SRRM2 CEP170B | 2.07e-05 | 464 | 226 | 17 | int:GSK3A |
| Interaction | DTX2 interactions | BCL9L NCOA3 MBNL1 ETV3 DAG1 ARHGEF11 ARID5A NFIX RPRD2 PLEKHA7 IKZF3 NUP98 JMJD1C R3HDM1 | 2.31e-05 | 330 | 226 | 14 | int:DTX2 |
| Interaction | WWTR1 interactions | SYNRG NCOA6 TNIP1 ARID1A ARID5A TOX4 OSBPL9 RPRD2 TTC28 DIDO1 SPECC1L JMJD1C SETD2 KMT2D PHACTR4 MAP3K2 | 2.40e-05 | 422 | 226 | 16 | int:WWTR1 |
| Interaction | TLX3 interactions | BCL9L NCOA3 NCOA6 ARID1A CIC KMT2C NFIX ITIH6 FOXK1 KMT2D ZFHX4 ARMC5 ZFHX3 | 2.66e-05 | 291 | 226 | 13 | int:TLX3 |
| Interaction | NFIB interactions | 3.29e-05 | 142 | 226 | 9 | int:NFIB | |
| Interaction | PAX8 interactions | 3.62e-05 | 111 | 226 | 8 | int:PAX8 | |
| Interaction | SP7 interactions | BCL9L NCOA3 NCOA6 MBNL1 ARID1A CIC KMT2C NFIX RPRD2 FOXK1 TSHZ3 KMT2D ZFHX4 | 4.18e-05 | 304 | 226 | 13 | int:SP7 |
| Interaction | TOP3B interactions | RNF223 SYNRG NCOA6 REPS1 PPRC1 THAP8 ARID1A ARHGEF11 BIRC6 TNFRSF21 AHDC1 CIC JAK3 KMT2C TNRC18 NAV1 MMP14 FOXK1 CRYBG2 NUP214 PRKRIP1 REV3L KANSL3 NHSL1 GAS2L1 KMT2D SHANK2 MEGF8 CSPG4 LRP4 TNK2 DOT1L SPEN CEP170B | 4.45e-05 | 1470 | 226 | 34 | int:TOP3B |
| Interaction | RARG interactions | 4.63e-05 | 58 | 226 | 6 | int:RARG | |
| Interaction | CREBBP interactions | NCOA3 NCOA6 SERTAD2 GMEB2 ARID1A RXRA ARID5A SUPT6H FOXO4 ANKS1A NPAT FOXM1 RBL2 ICAM1 SH3GL1 NUP98 KMT2D XAF1 NLK | 4.87e-05 | 599 | 226 | 19 | int:CREBBP |
| Interaction | FHL3 interactions | GCM2 ARID5A SHKBP1 POM121 MAP7D2 MMP14 FOXK1 IKZF3 TOPBP1 E2F8 HYAL2 MYBPC1 | 7.05e-05 | 276 | 226 | 12 | int:FHL3 |
| Interaction | PAX6 interactions | NCOA3 NCOA6 GCM2 ARID1A CIC KMT2C NFIX FOXK1 TSHZ3 IKZF3 KMT2D ZFHX4 USHBP1 ZFHX3 | 7.10e-05 | 366 | 226 | 14 | int:PAX6 |
| Interaction | YWHAB interactions | SYNRG MAP2 ARHGEF17 CIC SHKBP1 NAV1 FOXO4 SUCO PLEKHA7 FOXK1 ANKS1A TTC28 ARHGAP23 COBLL1 DTL E2F8 NHSL1 PHACTR4 MACF1 DOT1L R3HDM1 SRRM2 CEP170B MAP3K2 OTOG SON | 7.48e-05 | 1014 | 226 | 26 | int:YWHAB |
| Interaction | YWHAZ interactions | SYNRG MAP2 U2AF2 TNIP1 SYNPO ARID1A SPATA2 SQOR CIC NAV1 FOXO4 SUCO PLEKHA7 ANKRD40 FOXK1 ANKS1A TTC28 COBLL1 SH3GL1 DTL LCP2 E2F8 SPAG5 NHSL1 PHACTR4 MACF1 TNK2 R3HDM1 CEP170B MAP3K2 OTOG | 7.49e-05 | 1319 | 226 | 31 | int:YWHAZ |
| Interaction | SNRPB interactions | ACLY U2AF2 TNIP1 CIC DHX8 TOX4 SUPT6H RPRD2 IKZF3 ICAM1 DIDO1 PRKRIP1 SETD2 MACF1 IK SRRM2 SON | 7.93e-05 | 517 | 226 | 17 | int:SNRPB |
| Interaction | GATA2 interactions | 8.69e-05 | 199 | 226 | 10 | int:GATA2 | |
| Interaction | IKZF5 interactions | 8.85e-05 | 65 | 226 | 6 | int:IKZF5 | |
| Interaction | SOX5 interactions | 9.16e-05 | 162 | 226 | 9 | int:SOX5 | |
| Interaction | NRXN1 interactions | 9.43e-05 | 127 | 226 | 8 | int:NRXN1 | |
| Interaction | HNRNPLL interactions | 9.60e-05 | 163 | 226 | 9 | int:HNRNPLL | |
| Interaction | RNPS1 interactions | REPS1 U2AF2 DHX8 JAK3 SUPT6H FOXK1 FOXP3 CEP164 SETD2 DOT1L IK SRRM2 SDCBP2 NOS1AP SON | 9.67e-05 | 425 | 226 | 15 | int:RNPS1 |
| Interaction | SOX17 interactions | 9.73e-05 | 95 | 226 | 7 | int:SOX17 | |
| Interaction | FEV interactions | 1.03e-04 | 203 | 226 | 10 | int:FEV | |
| Interaction | SNRNP40 interactions | BCL9L MBNL1 U2AF2 GMEB2 ARID1A AHDC1 TASOR2 DHX8 CDCA2 POM121 SUPT6H NPAT SETD2 ZFHX3 DOT1L IK SRRM2 SPEN SON | 1.10e-04 | 637 | 226 | 19 | int:SNRNP40 |
| Interaction | ASF1A interactions | NCOA6 INCENP BCORL1 TNIP1 ARID1A TASOR2 CDCA2 NPAT KMT2D DOT1L SPEN | 1.23e-04 | 249 | 226 | 11 | int:ASF1A |
| Interaction | VASP interactions | SYNRG CTU2 REPS1 FOXK1 COBLL1 SH3GL1 SPAG5 NHSL1 PHACTR4 LRP4 FMN2 CEP170B | 1.28e-04 | 294 | 226 | 12 | int:VASP |
| Interaction | CBX3 interactions | BRPF3 INCENP ACLY BCORL1 AHDC1 CIC DHX8 CDCA2 TRIM66 IKZF3 COBLL1 TOPBP1 SETD2 CCDC71 SBNO1 MACF1 ZNF518B SRRM2 SPEN | 1.31e-04 | 646 | 226 | 19 | int:CBX3 |
| Interaction | NUP50 interactions | ARID1A DHX8 CDCA2 POM121 SUPT6H RPRD2 NPAT NUP98 NUP214 SBNO1 SRRM2 SPEN SON | 1.33e-04 | 341 | 226 | 13 | int:NUP50 |
| Interaction | SHANK3 interactions | BCL9L MAP2 MAP4 ACLY SYNPO TASOR2 SGIP1 ANK2 SPAG5 TDRD7 SPTBN4 SETD2 SHANK2 MACF1 ZFHX3 MYO15A | 1.60e-04 | 496 | 226 | 16 | int:SHANK3 |
| Interaction | DCTN1 interactions | EMC3 MAP2 MAP4 TNIP1 NAV1 MAP7D2 BICD2 PRR36 RBL2 SPECC1L SPAG5 CCNB1 KIAA1217 MACF1 DOT1L CEP170B | 1.64e-04 | 497 | 226 | 16 | int:DCTN1 |
| Interaction | SOX15 interactions | 1.95e-04 | 141 | 226 | 8 | int:SOX15 | |
| Interaction | GUSBP5 interactions | 1.97e-04 | 75 | 226 | 6 | int:GUSBP5 | |
| Interaction | KCTD13 interactions | MAP2 MAP4 ACLY TNIP1 SYNPO ARID1A ARHGEF11 ARHGEF17 ELFN2 ASAP1 SACS OSBPL9 NAV1 MAP7D2 PLEKHA7 SGIP1 ANK2 ARHGAP23 PRR36 CARMIL1 SH3GL1 SPECC1L RUFY3 SPTBN4 NHSL1 GAS2L1 SHANK2 MICAL2 KIAA1217 MACF1 CEP170B | 2.02e-04 | 1394 | 226 | 31 | int:KCTD13 |
| Interaction | RBBP7 interactions | STAG1 U2AF2 TNIP1 ARID1A BIRC6 CIC PYHIN1 TNRC18 ARHGAP25 FOXK1 NPAT IKZF3 TTC28 CCDC71 DOT1L SPEN | 2.05e-04 | 507 | 226 | 16 | int:RBBP7 |
| Interaction | NDC80 interactions | TNIP1 BIRC6 NAV1 MAP7D2 BICD2 CEP164 SPAG5 CCNB1 NHSL1 USHBP1 KIAA1217 CEP170B | 2.22e-04 | 312 | 226 | 12 | int:NDC80 |
| Interaction | TRIM36 interactions | 2.25e-04 | 144 | 226 | 8 | int:TRIM36 | |
| Interaction | ZFHX3 interactions | 2.30e-04 | 109 | 226 | 7 | int:ZFHX3 | |
| Interaction | BFSP1 interactions | 2.87e-04 | 52 | 226 | 5 | int:BFSP1 | |
| Interaction | H3-3A interactions | STAG1 INCENP BCORL1 U2AF2 SYNPO CIC DHX8 CDCA2 KMT2C FOXK1 NPAT TSHZ3 TOPBP1 DIDO1 JMJD1C KMT2D CCDC71 SBNO1 DOT1L SPEN | 3.12e-04 | 749 | 226 | 20 | int:H3-3A |
| Interaction | XRCC6 interactions | NCOA6 MAP4 U2AF2 TNIP1 RXRA CIC DHX8 PYHIN1 CDCA2 TNRC18 TOX4 RPRD2 IKZF3 ICAM1 DIDO1 SKIL JMJD1C CCNB1 ARMC5 ZFHX3 IK SRRM2 SPEN | 3.22e-04 | 928 | 226 | 23 | int:XRCC6 |
| Interaction | NUP35 interactions | BCL9L NCOA3 NCOA6 MBNL1 ARID1A AHDC1 CIC KMT2C POM121 FOXK1 NUP98 NUP214 JMJD1C KMT2D | 3.26e-04 | 424 | 226 | 14 | int:NUP35 |
| Interaction | NKX2-4 interactions | 3.66e-04 | 13 | 226 | 3 | int:NKX2-4 | |
| Interaction | SMC5 interactions | NCOA6 INCENP MAP4 MBNL1 BCORL1 U2AF2 ARID1A CIC TASOR2 CDCA2 TOX4 RPRD2 NPAT NUP98 TOPBP1 DIDO1 NUP214 REV3L JMJD1C SETD2 IK SRRM2 SPEN SON | 3.80e-04 | 1000 | 226 | 24 | int:SMC5 |
| Interaction | IRF4 interactions | 3.89e-04 | 85 | 226 | 6 | int:IRF4 | |
| Interaction | PAX2 interactions | 3.89e-04 | 85 | 226 | 6 | int:PAX2 | |
| Interaction | CCDC6 interactions | SYNRG MAP4 TNIP1 NAV1 BICD2 ATF5 TTC28 RUFY3 CCNB1 KIAA1217 CEP170B | 4.04e-04 | 286 | 226 | 11 | int:CCDC6 |
| Interaction | RBBP5 interactions | NCOA6 INCENP ARID1A PYHIN1 KMT2C NFIX FOXP3 KANSL3 KMT2D SRRM2 SPEN | 4.16e-04 | 287 | 226 | 11 | int:RBBP5 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.15e-06 | 15 | 138 | 4 | 529 | |
| GeneFamily | CD molecules|Mucins | 1.76e-05 | 21 | 138 | 4 | 648 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.26e-04 | 34 | 138 | 4 | 487 | |
| GeneFamily | Beta-gamma crystallin domain containing | 1.73e-04 | 3 | 138 | 2 | 1360 | |
| GeneFamily | Fibronectin type III domain containing | 2.29e-04 | 160 | 138 | 7 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.38e-04 | 161 | 138 | 7 | 593 | |
| GeneFamily | Forkhead boxes | 3.18e-04 | 43 | 138 | 4 | 508 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.83e-04 | 181 | 138 | 7 | 694 | |
| GeneFamily | PHD finger proteins | 6.30e-04 | 90 | 138 | 5 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 8.85e-04 | 25 | 138 | 3 | 775 | |
| GeneFamily | Nucleoporins | 1.84e-03 | 32 | 138 | 3 | 1051 | |
| GeneFamily | THAP domain containing | 3.63e-03 | 12 | 138 | 2 | 65 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.04e-03 | 206 | 138 | 6 | 682 | |
| GeneFamily | AT-rich interaction domain containing | 5.69e-03 | 15 | 138 | 2 | 418 | |
| GeneFamily | PDZ domain containing | 6.23e-03 | 152 | 138 | 5 | 1220 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 6.56e-03 | 50 | 138 | 3 | 721 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE | INCENP MAP2 GGN SERTAD2 ETV3 TNFRSF21 CIC ASAP1 DHX8 POM121 IER3 FOXO4 ICAM1 SKIL JMJD1C MICAL2 | 1.38e-07 | 368 | 225 | 16 | M41100 |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | LGMN BCL9L TASOR2 TOX4 CRYBG1 C1orf159 BICD2 DXO RBL2 JMJD1C HAAO TNXB | 1.77e-07 | 200 | 225 | 12 | M387 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 PPRC1 SERTAD2 AHDC1 SACS SUCO NPAT TENT4A DIDO1 REV3L CCNB1 MICAL2 CBFA2T2 SPEN | 3.65e-07 | 300 | 225 | 14 | M8702 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 STAG1 MBNL1 MGLL AHDC1 SACS IER3 SUCO ANKS1A NPAT DPYD TTC28 NUP98 TOPBP1 SPECC1L REV3L TDRD7 SETD2 MICAL2 MACF1 ZFHX3 R3HDM1 SPEN SON | 4.06e-07 | 856 | 225 | 24 | M4500 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 1.11e-06 | 157 | 225 | 10 | M7733 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | NCOA3 SYNRG MBNL1 SERTAD2 ARID1A BIRC6 ARID5A ASAP1 PYHIN1 JAK3 KMT2C SACS CRYBG1 ARHGAP25 NPAT BICD2 IKZF3 RBL2 NUP98 NLRP1 REV3L LCP2 JMJD1C SETD2 KMT2D SBNO1 MACF1 TNK2 IK SPEN MAP3K2 SON | 1.70e-06 | 1492 | 225 | 32 | M40023 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | PPRC1 U2AF2 ARHGEF11 CIC FOXO4 DXO ATF5 NUP214 SEC31B KMT2D TNK2 DOT1L SRRM2 | 8.00e-06 | 338 | 225 | 13 | M17094 |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN | TNFRSF21 TROAP DTL CBFA2T3 E2F8 RUFY3 SPAG5 CCNB1 PTCH2 MUC6 | 9.24e-06 | 199 | 225 | 10 | M8029 |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 1.42e-05 | 166 | 225 | 9 | M7722 | |
| Coexpression | HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP | 2.02e-05 | 39 | 225 | 5 | M2550 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.52e-05 | 137 | 225 | 8 | M39241 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | INCENP NEXMIF SLC6A17 SYT9 CDCA2 MAP7D2 NPAT FOXM1 TROAP DTL TOPBP1 REV3L E2F8 RUFY3 SPAG5 CCNB1 FMN2 DOT1L | 2.62e-05 | 680 | 225 | 18 | MM456 |
| Coexpression | GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP | NCOA3 SERTAD2 TNIP1 PYHIN1 CRYBG1 TTC28 TENT4A KIAA1217 ORAI3 | 2.70e-05 | 180 | 225 | 9 | M6721 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | MAP2 TSHZ2 SLC6A17 SSPOP DSCAML1 AHDC1 KIAA1549L NFIX NAV1 MAP7D2 IKZF3 ANK2 ARHGAP23 REV3L SEC31B RUFY3 SHANK2 ZFHX4 TNK2 ROBO2 ZFHX3 R3HDM1 NLK MAP3K2 | 3.11e-05 | 1106 | 225 | 24 | M39071 |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 4.48e-05 | 192 | 225 | 9 | M8272 | |
| Coexpression | BENPORATH_CYCLING_GENES | NCOA3 STAG1 CIC DHX8 POM121 ARHGAP8 NPAT FOXM1 TROAP DTL NUP98 TOPBP1 JMJD1C E2F8 SPAG5 CCNB1 MAP3K2 | 4.92e-05 | 648 | 225 | 17 | M8156 |
| Coexpression | GSE22033_WT_VS_PPARG_KO_MEF_UP | 5.06e-05 | 195 | 225 | 9 | M7694 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBM | MAP2 DSCAML1 NFIX NAV1 ANK2 ZMAT4 SEC31B RUFY3 ZFHX4 CBFA2T2 FMN2 | 5.31e-05 | 295 | 225 | 11 | M39063 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 STAG1 MBNL1 MGLL ANKS1A DPYD NUP98 TOPBP1 SPECC1L REV3L TDRD7 SETD2 R3HDM1 SPEN | 5.56e-05 | 466 | 225 | 14 | M13522 |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 5.69e-05 | 198 | 225 | 9 | M9778 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 5.92e-05 | 199 | 225 | 9 | M8031 | |
| Coexpression | GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN | 6.15e-05 | 200 | 225 | 9 | M8602 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | TNFRSF21 CDCA2 METTL25 ANKS1A FOXM1 ANPEP TROAP SPAG5 CCNB1 ZFHX4 PTCH2 | 6.17e-05 | 300 | 225 | 11 | M45675 |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_PR_DN | 6.25e-05 | 49 | 225 | 5 | M10412 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_ENDOTHELIAL_CELL_AGEING | SERTAD2 MGLL CIC KCNB1 IER3 TTC28 CBFA2T3 SKIL USHBP1 TNXB MAP3K2 | 6.36e-05 | 301 | 225 | 11 | MM3813 |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | LGMN NCOA3 MAP2 CLTRN MGLL SQOR KCNB1 MAP7D2 PLEKHA7 ATF5 ANPEP COBLL1 ICAM1 NUP98 REV3L TDRD7 SHANK2 ZFHX4 KIAA1217 FMN2 ZFHX3 XAF1 | 8.87e-05 | 1033 | 225 | 22 | M4196 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 9.82e-05 | 166 | 225 | 8 | M6826 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 9.93e-05 | 86 | 225 | 6 | M39248 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | BNC2 MAP2 TSHZ2 SLC6A17 ELFN2 AHDC1 KIAA1549L MAP7D2 ANK2 REV3L RUFY3 SHANK2 ZFHX4 FMN2 TNK2 ROBO2 ZFHX3 | 1.32e-04 | 703 | 225 | 17 | M39070 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | NEXMIF CIC NFIX DPYD CBFA2T3 SEC31B CEP164 SPTBN4 SHANK2 PHACTR4 DOT1L NLK | 1.48e-04 | 389 | 225 | 12 | M39102 |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | STAG1 LRRC37A2 ARID1A TNFRSF21 CDCA2 POM121 SACS NAV1 FOXM1 DTL DIDO1 CCNB1 SETD2 | 1.65e-04 | 454 | 225 | 13 | M19927 |
| Coexpression | MASSARWEH_TAMOXIFEN_RESISTANCE_UP | MYLK SRARP BLNK DAG1 SQOR IER3 NFIX PLEKHA7 COBLL1 DIDO1 SKIL SHANK2 KIAA1217 LYPD3 RAI2 | 1.69e-04 | 583 | 225 | 15 | M17454 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 2.05e-04 | 139 | 225 | 7 | M8948 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | MAP2 TSHZ2 NAV1 MAP7D2 USH2A ANK2 SEC31B SHANK2 ZFHX4 FMN2 ROBO2 ZFHX3 DOT1L | 2.08e-04 | 465 | 225 | 13 | M39066 |
| Coexpression | BURTON_ADIPOGENESIS_3 | 2.41e-04 | 101 | 225 | 6 | M1577 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 2.44e-04 | 294 | 225 | 10 | M40873 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | TSHZ2 UNC5B SYNPO SQOR ARID5A IER3 SGIP1 ANK2 ANPEP CBFA2T3 MTFMT ADAMTS12 LYPD3 ORAI3 RAI2 | 2.47e-04 | 604 | 225 | 15 | M45760 |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 2.48e-04 | 190 | 225 | 8 | M761 | |
| Coexpression | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN | 2.51e-04 | 36 | 225 | 4 | M15473 | |
| Coexpression | KAUFFMANN_DNA_REPLICATION_GENES | 2.76e-04 | 146 | 225 | 7 | M9372 | |
| Coexpression | BURTON_ADIPOGENESIS_3 | 2.82e-04 | 104 | 225 | 6 | MM1180 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 2.86e-04 | 194 | 225 | 8 | M6082 | |
| Coexpression | PEREZ_TP53_TARGETS | UNC5B MBNL1 BLNK ARHGEF17 ELFN2 AHDC1 LRRC37A KCNB1 MAP7D2 PLEKHA7 CRYBG2 MXRA5 ARHGAP23 ADAMTS2 ETV7 DIDO1 NLRP1 CBFA2T3 CEP164 KIAA1217 CSPG4 XAF1 CEP170B | 2.88e-04 | 1201 | 225 | 23 | M4391 |
| Coexpression | RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP | 3.00e-04 | 148 | 225 | 7 | M39016 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN | 3.06e-04 | 196 | 225 | 8 | M9979 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 3.17e-04 | 197 | 225 | 8 | M8980 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN | 3.17e-04 | 197 | 225 | 8 | M6835 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 3.17e-04 | 197 | 225 | 8 | M3193 | |
| Coexpression | GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN | 3.17e-04 | 197 | 225 | 8 | M5760 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 3.27e-04 | 198 | 225 | 8 | M9386 | |
| Coexpression | GSE6259_BCELL_VS_CD8_TCELL_DN | 3.27e-04 | 198 | 225 | 8 | M6736 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS | 3.29e-04 | 107 | 225 | 6 | M39165 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN | 3.39e-04 | 199 | 225 | 8 | M3731 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN | 3.39e-04 | 199 | 225 | 8 | M9959 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 3.39e-04 | 199 | 225 | 8 | M9124 | |
| Coexpression | GSE14308_TH17_VS_NATURAL_TREG_DN | 3.50e-04 | 200 | 225 | 8 | M3390 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TREG_DN | 3.50e-04 | 200 | 225 | 8 | M3233 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 3.50e-04 | 200 | 225 | 8 | M3580 | |
| Coexpression | GSE17721_CTRL_VS_CPG_6H_BMDC_DN | 3.50e-04 | 200 | 225 | 8 | M3765 | |
| Coexpression | GSE17721_CTRL_VS_CPG_1H_BMDC_DN | 3.50e-04 | 200 | 225 | 8 | M3757 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP | 3.50e-04 | 200 | 225 | 8 | M7159 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN | 3.50e-04 | 200 | 225 | 8 | M6417 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 3.50e-04 | 200 | 225 | 8 | M7831 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN | 3.50e-04 | 200 | 225 | 8 | M4269 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 3.50e-04 | 200 | 225 | 8 | M9260 | |
| Coexpression | GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN | 3.50e-04 | 200 | 225 | 8 | M4346 | |
| Coexpression | GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 3.50e-04 | 200 | 225 | 8 | M6997 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | INCENP DAG1 CDCA2 PLEKHA7 FOXM1 DTL RFX4 E2F8 SPAG5 ZFHX4 LRP4 NLK | 3.85e-04 | 432 | 225 | 12 | MM419 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP | MAP4 BLNK SQOR RXRA RPRD2 GPBAR1 DPYD IKZF3 NUP214 RUFY3 SBNO1 ORAI3 XAF1 SLC24A1 | 3.85e-04 | 562 | 225 | 14 | M41008 |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_UP | LGMN BCL9L MAP4 ACLY DAG1 TNIP1 SUPT6H NAV1 ICAM1 DIDO1 MICAL2 ORAI3 | 3.93e-04 | 433 | 225 | 12 | M2240 |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_UP | 4.00e-04 | 111 | 225 | 6 | M7357 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 4.55e-04 | 208 | 225 | 8 | MM581 | |
| Coexpression | HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP | 4.58e-04 | 42 | 225 | 4 | M41024 | |
| Coexpression | FORTSCHEGGER_PHF8_TARGETS_DN | HMGN2P46 MYLK MBNL1 TNIP1 MGLL SYNPO SQOR TNFRSF21 JAK3 PLEKHA7 CRYBG2 MEGF8 MICAL2 LYPD3 TNK2 TNXB MAP3K2 | 4.59e-04 | 783 | 225 | 17 | M2488 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NCOA3 BNC2 MYLK MAP4 TSHZ2 CLTRN BCORL1 DAG1 BIRC6 CDCA2 KMT2C TNRC18 NFIX NAV1 MMP14 DPYD ADAMTS2 DIDO1 JMJD1C RUFY3 KIAA1217 PTCH2 ROBO2 R3HDM1 MYBPC1 | 8.88e-07 | 790 | 222 | 25 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NCOA3 BNC2 MAP4 TSHZ2 UNC5B CLTRN BCORL1 DAG1 BIRC6 KMT2C TNRC18 NFIX NAV1 MMP14 ADAMTS2 DIDO1 JMJD1C RUFY3 KIAA1217 PTCH2 ROBO2 ZFHX3 R3HDM1 MYBPC1 | 3.82e-06 | 801 | 222 | 24 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | NCOA3 BNC2 MYLK MAP4 TSHZ2 CLTRN BCORL1 DAG1 BIRC6 KMT2C TNRC18 NFIX NAV1 MMP14 ADAMTS2 COBLL1 JMJD1C KIAA1217 PTCH2 XAF1 R3HDM1 TNXB | 3.60e-05 | 799 | 222 | 22 | gudmap_developingGonad_e18.5_epididymis_1000 |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | BNC2 MYLK TSHZ2 MMP14 MXRA5 SGIP1 ANK2 ADAMTS2 ADAMTS12 ROBO2 PDZRN3 | 5.43e-09 | 194 | 228 | 11 | 03a269f75a481ea54aea8e6444605db8d6df493d |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | BNC2 MYLK IGSF10 MMP14 ANK2 SPECC1L REV3L ADAMTS12 MACF1 TNXB PDZRN3 | 7.07e-09 | 199 | 228 | 11 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.86e-08 | 183 | 228 | 10 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.50e-08 | 186 | 228 | 10 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | BNC2 MYLK TSHZ2 SSC5D SGIP1 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 4.73e-08 | 187 | 228 | 10 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | MBNL1 BIRC6 TASOR2 KMT2C SUCO IKZF3 JMJD1C MACF1 SPEN MAP3K2 | 4.98e-08 | 188 | 228 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-Cycling_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 5.78e-08 | 191 | 228 | 10 | aa9c0b1b90cdb7a95d4e6332819f82cae0a79ff9 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | BNC2 MYLK SGIP1 ANK2 ADAMTS2 ADAMTS12 MACF1 ROBO2 TNXB PDZRN3 | 5.78e-08 | 191 | 228 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | BNC2 MYLK SGIP1 ANK2 ADAMTS2 ADAMTS12 MACF1 ROBO2 TNXB PDZRN3 | 6.07e-08 | 192 | 228 | 10 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | BNC2 MYLK TSHZ2 TSHZ3 SGIP1 TTC28 ADAMTS2 ADAMTS12 ROBO2 PDZRN3 | 6.37e-08 | 193 | 228 | 10 | acad568621ed677031797b8c2e34dafea798d681 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | BNC2 MYLK TSHZ2 TSHZ3 SGIP1 TTC28 ADAMTS2 ADAMTS12 ROBO2 PDZRN3 | 6.69e-08 | 194 | 228 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.02e-08 | 195 | 228 | 10 | 751cb00b0f3005be6b645adadfbb9dd2215b6e08 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-08 | 195 | 228 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | MYLK TSHZ2 TSHZ3 SGIP1 TTC28 CARMIL1 ADAMTS12 ZFHX4 MACF1 ROBO2 | 7.02e-08 | 195 | 228 | 10 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-08 | 195 | 228 | 10 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-08 | 195 | 228 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | BNC2 MYLK TSHZ2 DPYD ADAMTS2 CARMIL1 ADAMTS12 MACF1 ROBO2 PDZRN3 | 7.36e-08 | 196 | 228 | 10 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | BNC2 MYLK TSHZ2 IGSF10 SGIP1 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 7.36e-08 | 196 | 228 | 10 | bc94909f9b2dc08a59eef1914148b69720569c8f |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | BNC2 MYLK SGIP1 ANK2 ADAMTS2 ADAMTS12 MACF1 ROBO2 TNXB PDZRN3 | 7.36e-08 | 196 | 228 | 10 | 7d8505dac15fa59935ccf592afc54b04c4c6554f |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | BNC2 MYLK TSHZ2 SGIP1 ANK2 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 8.10e-08 | 198 | 228 | 10 | 26e55b409db2a1637c95fae7c54b0abea1ef550c |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RXRA KMT2C IER3 MUC17 DPYD ANPEP ADAMTS2 ICAM1 JMJD1C MICAL2 | 8.10e-08 | 198 | 228 | 10 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | BNC2 MYLK TSHZ2 TSHZ3 SGIP1 TTC28 ADAMTS2 ADAMTS12 ROBO2 PDZRN3 | 8.10e-08 | 198 | 228 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | BNC2 MYLK SGIP1 ANK2 ADAMTS2 ADAMTS12 MACF1 ROBO2 TNXB PDZRN3 | 8.10e-08 | 198 | 228 | 10 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | MYLK IGSF10 MMP14 MXRA5 ANK2 SPECC1L REV3L MACF1 TNXB PDZRN3 | 8.49e-08 | 199 | 228 | 10 | e1849505b92820a219c5a2c35492bdd55579fb48 |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | BNC2 MYLK TSHZ2 SGIP1 TTC28 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 8.49e-08 | 199 | 228 | 10 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-08 | 199 | 228 | 10 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | MYLK TSHZ2 SSC5D MMP14 ADAMTS12 ZFHX4 LRP4 ROBO2 TNXB PDZRN3 | 8.49e-08 | 199 | 228 | 10 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | MYLK IGSF10 MMP14 ANK2 SPECC1L REV3L ADAMTS12 MACF1 TNXB PDZRN3 | 8.89e-08 | 200 | 228 | 10 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 MYLK TSHZ2 SGIP1 ANK2 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 8.89e-08 | 200 | 228 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | INCENP DAG1 C1orf159 FOXM1 DTL E2F8 CCNB1 MICAL2 ARMC5 DOT1L | 8.89e-08 | 200 | 228 | 10 | 4e489ecf472857357d45e9f6c7a812aa48b72ebf |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 MYLK TSHZ2 SGIP1 ANK2 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 8.89e-08 | 200 | 228 | 10 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 MYLK TSHZ2 SGIP1 ANK2 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 8.89e-08 | 200 | 228 | 10 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | BNC2 MYLK TSHZ2 SGIP1 ANK2 ADAMTS2 ADAMTS12 ROBO2 TNXB PDZRN3 | 8.89e-08 | 200 | 228 | 10 | 311fab076f2ceb258e3970eb21e39344b894042a |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.28e-07 | 176 | 228 | 9 | 581045e61cdcdfa85701343d1a7c0a72a36606a7 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.28e-07 | 176 | 228 | 9 | d30241fb8119834d6e7b59efec3f92fc7a3d1247 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 4.56e-07 | 183 | 228 | 9 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 4.99e-07 | 185 | 228 | 9 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-07 | 185 | 228 | 9 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | NCOA3 ARID1A TNRC18 TTC28 CARMIL1 CBFA2T2 PHACTR4 LRP4 R3HDM1 | 5.22e-07 | 186 | 228 | 9 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | NCOA3 ARID1A TNRC18 TTC28 CARMIL1 CBFA2T2 PHACTR4 LRP4 R3HDM1 | 5.22e-07 | 186 | 228 | 9 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-07 | 187 | 228 | 9 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-07 | 187 | 228 | 9 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.46e-07 | 187 | 228 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.97e-07 | 189 | 228 | 9 | f4865b7db16de15120504147a8016ac522ad242a | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.24e-07 | 190 | 228 | 9 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.52e-07 | 191 | 228 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.81e-07 | 192 | 228 | 9 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-07 | 192 | 228 | 9 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.11e-07 | 193 | 228 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-07 | 193 | 228 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-07 | 193 | 228 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 7.43e-07 | 194 | 228 | 9 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | MAP2 TSHZ2 ARHGEF17 SGIP1 ADAMTS2 ADAMTS12 MICAL2 CSPG4 ZFHX3 | 8.09e-07 | 196 | 228 | 9 | b8759e6231e0254797d6c30930407b79440c57bb |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-07 | 196 | 228 | 9 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-07 | 196 | 228 | 9 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-07 | 196 | 228 | 9 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.44e-07 | 197 | 228 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.44e-07 | 197 | 228 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.44e-07 | 197 | 228 | 9 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.44e-07 | 197 | 228 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.81e-07 | 198 | 228 | 9 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-07 | 198 | 228 | 9 | b027a141ab531d0f5d6a26811a53427e7b0771dd | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.81e-07 | 198 | 228 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.81e-07 | 198 | 228 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.81e-07 | 198 | 228 | 9 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.81e-07 | 198 | 228 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.81e-07 | 198 | 228 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.18e-07 | 199 | 228 | 9 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.18e-07 | 199 | 228 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-07 | 199 | 228 | 9 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.18e-07 | 199 | 228 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.18e-07 | 199 | 228 | 9 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.57e-07 | 200 | 228 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Sigmoid-(1)_T_cell-(18)_cycling_gd_T|Sigmoid / shred on region, Cell_type, and subtype | 9.57e-07 | 200 | 228 | 9 | 6e367abd1a4b87e20eb9095b8337723163e8bbae | |
| ToppCell | Sigmoid-T_cell-cycling_gd_T|Sigmoid / Region, Cell class and subclass | 9.57e-07 | 200 | 228 | 9 | 9769185abae084ffac36420c749625e679b70ca8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.57e-07 | 200 | 228 | 9 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.57e-07 | 200 | 228 | 9 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 155 | 228 | 8 | 51f6447945389649d99dcf7603b396195c631ead | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 155 | 228 | 8 | 23dc71cab28094ca0ac4d2baf4e24871ed107781 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 160 | 228 | 8 | 8a7a73b0ee1877fe02d47f745d36ae2858b529e1 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-06 | 161 | 228 | 8 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 2.13e-06 | 164 | 228 | 8 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.55e-06 | 168 | 228 | 8 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-06 | 170 | 228 | 8 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-06 | 171 | 228 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-06 | 171 | 228 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.04e-06 | 172 | 228 | 8 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 3.31e-06 | 174 | 228 | 8 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.91e-06 | 178 | 228 | 8 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 179 | 228 | 8 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 179 | 228 | 8 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 179 | 228 | 8 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.08e-06 | 179 | 228 | 8 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | NCOA6 STAG1 PPRC1 GMEB2 ARID1A RXRA RPRD2 ATF5 DIDO1 REV3L CBFA2T3 MCM9 ZFHX3 SRRM2 | 1.53e-09 | 170 | 224 | 14 | 1050_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | NCOA6 STAG1 PPRC1 GMEB2 ARID1A RXRA RPRD2 DIDO1 CBFA2T3 E2F8 MCM9 ZFHX3 SRRM2 SON | 1.78e-09 | 172 | 224 | 14 | 1072_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | NCOA6 PPRC1 ARID1A RXRA RPRD2 ATF5 TENT4A COBLL1 DIDO1 CBFA2T3 ZFHX3 SRRM2 SPEN | 2.53e-08 | 178 | 224 | 13 | 1112_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | STAG1 GMEB2 ARID1A RXRA RPRD2 TARBP2 DIDO1 CBFA2T3 RUFY3 MCM9 SRRM2 HYAL2 | 1.87e-07 | 176 | 224 | 12 | 2639_DN |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | DAG1 UBAP1 ARID1A FOXM1 DPYD ICAM1 PRKRIP1 CEP164 CCNB1 SETD2 SBNO1 PHACTR4 | 5.33e-07 | 194 | 224 | 12 | 2009_DN |
| Drug | novobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A | NCOA3 MAP4 RXRA MMP14 ANKRD40 NPAT BICD2 ADAMTS2 RBL2 SH3GL1 PRKRIP1 RUFY3 | 6.28e-07 | 197 | 224 | 12 | 435_DN |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | NCOA6 STAG1 GMEB2 ARID1A RXRA RPRD2 ATF5 DIDO1 CBFA2T3 MCM9 ZFHX3 | 1.37e-06 | 175 | 224 | 11 | 1058_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | STAG1 PPRC1 U2AF2 GMEB2 ARID1A RPRD2 REV3L CBFA2T3 MCM9 SLC24A1 SRRM2 | 1.61e-06 | 178 | 224 | 11 | 6276_DN |
| Drug | Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | SYNPO ARHGEF11 FOXP3 ANK2 ANPEP NUP214 CEP164 SPTBN4 R3HDM1 MYO15A NOS1AP | 4.11e-06 | 196 | 224 | 11 | 3171_UP |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A | PPRC1 BCORL1 DAG1 ARID1A RPRD2 DPYD ICAM1 SH3GL1 PRKRIP1 SETD2 MACF1 | 4.31e-06 | 197 | 224 | 11 | 2034_DN |
| Drug | Propranolol hydrochloride [318-98-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A | MAP4 UNC5B CIC SUPT6H ZNF282 TTC28 COBLL1 ICAM1 ZFHX4 ORAI3 ZFHX3 | 4.75e-06 | 199 | 224 | 11 | 5358_UP |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | ARID1A CIC SUPT6H C1orf159 ATF5 ANPEP PRR36 SH3D21 PHACTR4 SLC24A1 SRRM2 | 4.99e-06 | 200 | 224 | 11 | 3322_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | STAG1 GMEB2 ARID1A RXRA COBLL1 DIDO1 CBFA2T3 RUFY3 MCM9 SRRM2 | 5.16e-06 | 163 | 224 | 10 | 7453_DN |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.11e-06 | 169 | 224 | 10 | 5572_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | STAG1 U2AF2 GMEB2 ARID1A RXRA ATF5 CBFA2T3 MCM9 SRRM2 MAP3K2 | 8.30e-06 | 172 | 224 | 10 | 5209_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.74e-06 | 173 | 224 | 10 | 3243_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 9.19e-06 | 174 | 224 | 10 | 7530_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | NCOA6 PPRC1 GMEB2 ARID1A RXRA ZNF282 CBFA2T3 RUFY3 MCM9 SRRM2 | 9.66e-06 | 175 | 224 | 10 | 1014_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | MAP4 U2AF2 GMEB2 ARID1A RXRA RPRD2 ZNF282 CBFA2T3 MCM9 SRRM2 | 1.02e-05 | 176 | 224 | 10 | 1535_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.12e-05 | 178 | 224 | 10 | 7245_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.12e-05 | 178 | 224 | 10 | 1672_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | STAG1 PPRC1 GMEB2 ARID1A RXRA TARBP2 DIDO1 RUFY3 SLC24A1 SRRM2 | 1.18e-05 | 179 | 224 | 10 | 6609_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | BNC2 STAG1 SYNPO GMEB2 ARID1A RPRD2 ATF5 DIDO1 PRKRIP1 RUFY3 | 1.24e-05 | 180 | 224 | 10 | 1793_DN |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A | STAG1 PPRC1 DAG1 NFIX MMP14 ZNF282 TARBP2 ATF5 SLC24A1 SRRM2 | 1.43e-05 | 183 | 224 | 10 | 4527_DN |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; HL60; HT_HG-U133A | SPATA2 AHDC1 SUPT6H ICAM1 NLRP1 SEC31B CEP164 CBFA2T2 R3HDM1 HYAL2 | 2.07e-05 | 191 | 224 | 10 | 3123_DN |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; PC3; HT_HG-U133A | NCOA3 ARID1A KIAA1549L ICAM1 RUFY3 SETD2 MCM9 PHACTR4 NLK MAP3K2 | 2.26e-05 | 193 | 224 | 10 | 5839_DN |
| Drug | Syk inhibitor | 2.47e-05 | 59 | 224 | 6 | CID006419747 | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A | MAP2 MAP4 ARHGEF17 ARID5A PRR36 ICAM1 SPTBN4 MICAL2 PTCH2 SLC24A1 | 2.58e-05 | 196 | 224 | 10 | 4288_UP |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | MYLK ARID1A TRIM66 SUPT6H ETV7 RNF17 ZFHX4 CBFA2T2 SRRM2 PDZRN3 | 2.58e-05 | 196 | 224 | 10 | 3256_UP |
| Drug | Roxithromycin [80214-83-1]; Up 200; 4.8uM; HL60; HT_HG-U133A | 2.70e-05 | 197 | 224 | 10 | 2992_UP | |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.82e-05 | 198 | 224 | 10 | 6746_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; HL60; HT_HG-U133A | NCOA3 MAP4 TNFRSF21 ARID5A FOXO4 COBLL1 SH3GL1 HAAO SLC24A1 MUC6 | 2.82e-05 | 198 | 224 | 10 | 2342_UP |
| Drug | sttC | 3.19e-05 | 7 | 224 | 3 | CID000081801 | |
| Drug | bepridil | 3.60e-05 | 126 | 224 | 8 | CID000002351 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.90e-05 | 165 | 224 | 9 | 2835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.49e-05 | 168 | 224 | 9 | 6820_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.40e-05 | 172 | 224 | 9 | 7179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.40e-05 | 172 | 224 | 9 | 3428_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.40e-05 | 172 | 224 | 9 | 2330_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.64e-05 | 173 | 224 | 9 | 2881_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 5.90e-05 | 174 | 224 | 9 | 909_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.17e-05 | 175 | 224 | 9 | 6316_DN | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 6.45e-05 | 176 | 224 | 9 | 6179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.45e-05 | 176 | 224 | 9 | 6784_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.74e-05 | 177 | 224 | 9 | 7550_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.74e-05 | 177 | 224 | 9 | 5308_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.03e-05 | 178 | 224 | 9 | 992_DN | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 7.03e-05 | 178 | 224 | 9 | 4444_DN | |
| Drug | 5109870; Down 200; 25uM; MCF7; HT_HG-U133A_EA | 7.34e-05 | 179 | 224 | 9 | 904_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.67e-05 | 180 | 224 | 9 | 6454_DN | |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 7.69e-05 | 104 | 224 | 7 | ctd:C000595015 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.00e-05 | 181 | 224 | 9 | 7077_DN | |
| Drug | AC1L1KMJ | MYLK MAP2 SACS MMP14 ANK2 RBL2 ICAM1 LCP2 SPTBN4 GAS2L1 MACF1 TNK2 MYO15A FCAMR MAP3K2 | 8.07e-05 | 476 | 224 | 15 | CID000030956 |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 8.34e-05 | 182 | 224 | 9 | 6896_DN | |
| Drug | semduramicin | 9.64e-05 | 2 | 224 | 2 | CID000071327 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A | 9.85e-05 | 186 | 224 | 9 | 2694_DN | |
| Drug | geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 9.85e-05 | 186 | 224 | 9 | 1066_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 9.85e-05 | 186 | 224 | 9 | 6874_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A | 1.11e-04 | 189 | 224 | 9 | 410_DN | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.11e-04 | 189 | 224 | 9 | 1285_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | U2AF2 ARHGEF11 ARID5A SUPT6H MMP14 CRYBG2 SH3D21 MEGF8 ZFHX3 | 1.16e-04 | 190 | 224 | 9 | 4274_UP |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.16e-04 | 190 | 224 | 9 | 4307_DN | |
| Drug | splitomicin; Up 200; 20uM; PC3; HG-U133A | 1.36e-04 | 194 | 224 | 9 | 661_UP | |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.41e-04 | 195 | 224 | 9 | 1649_DN | |
| Drug | Methiazole; Up 200; 15uM; PC3; HT_HG-U133A | ARHGEF17 PYHIN1 COBLL1 ZMAT4 ADAMTS12 KANSL3 CSPG4 LRP4 HAAO | 1.47e-04 | 196 | 224 | 9 | 3796_UP |
| Drug | chrysene | NCOA3 MYLK SERTAD2 TNIP1 MGLL TOX4 IER3 MMP14 ANPEP ARHGAP23 CARMIL1 ICAM1 DTL DIDO1 CBFA2T3 NHSL1 IK SRRM2 TNXB RAI2 MYBPC1 | 1.51e-04 | 871 | 224 | 21 | ctd:C031180 |
| Drug | LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2676_UP | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; HL60; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 2481_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 1.52e-04 | 197 | 224 | 9 | 6974_DN | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 2118_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 1633_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 3842_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 3743_UP | |
| Drug | Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; PC3; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 5885_DN | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 2797_UP | |
| Drug | Tomatidine [77-59-8]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 2746_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | DAG1 C1orf159 MMP14 SH3D21 RUFY3 SHANK2 ZFHX4 MYO15A CEP170B | 1.58e-04 | 198 | 224 | 9 | 2424_UP |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.58e-04 | 198 | 224 | 9 | 3423_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | MAP4 ARHGEF11 TNFRSF21 RBL2 SH3GL1 PRKRIP1 RUFY3 PCIF1 ZFHX3 | 1.58e-04 | 198 | 224 | 9 | 5298_DN |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.64e-04 | 199 | 224 | 9 | 3206_UP | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; PC3; HT_HG-U133A | 1.64e-04 | 199 | 224 | 9 | 1808_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HG-U133A | 1.71e-04 | 200 | 224 | 9 | 409_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.00e-04 | 161 | 224 | 8 | 4768_DN | |
| Disease | reaction time measurement | BNC2 REPS1 LRRC37A2 ELFN2 RXRA POM121 KIAA1549L NFIX BICD2 DXO DPYD TTC28 ARHGAP23 ADAMTS2 NLRP1 SETD2 KMT2D LRP4 ZFHX3 | 8.27e-07 | 658 | 225 | 19 | EFO_0008393 |
| Disease | Adenoid Cystic Carcinoma | 1.03e-06 | 100 | 225 | 8 | C0010606 | |
| Disease | testosterone measurement | NCOA6 SPEM3 STAG1 TSHZ2 MBNL1 BCORL1 SERTAD2 DAG1 UBAP1 ARID1A BIRC6 RXRA CDCA2 USH2A FOXM1 DXO ANK2 TTC28 COBLL1 IQCN JMJD1C ZFHX4 MCM9 MACF1 ZFHX3 MYO15A SLC24A1 | 1.74e-06 | 1275 | 225 | 27 | EFO_0004908 |
| Disease | pulse pressure measurement | BNC2 BRPF3 MBNL1 UBAP1 SSPOP AHDC1 ARID5A DHX8 TRIM66 KIAA1549L SUPT6H NAV1 PLEKHA7 MXRA5 SGIP1 ANK2 TTC28 CARMIL1 COBLL1 CEP164 SPTBN4 ZFHX4 MEGF8 KIAA1217 PHACTR4 ZFHX3 DOT1L IK | 2.96e-06 | 1392 | 225 | 28 | EFO_0005763 |
| Disease | Malignant neoplasm of breast | NCOA3 NCOA6 CTU2 SRARP BCORL1 LRRC37A2 TNIP1 ARID1A CIC LRRC37A MAP7D2 MMP14 FOXP3 FOXM1 DPYD ANK2 NUP98 NUP214 SETD2 KMT2D SBNO1 MACF1 SPEN | 8.95e-06 | 1074 | 225 | 23 | C0006142 |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 4.13e-05 | 121 | 225 | 7 | EFO_0004612, EFO_0005271 | |
| Disease | platelet crit | CTU2 STAG1 SERTAD2 DAG1 ARID1A ARHGEF11 NFIX RPRD2 ARHGAP25 NPAT PMS2P1 BICD2 TTC28 CARMIL1 DTL JMJD1C SH3D21 SBNO1 FMN2 DOT1L | 4.61e-05 | 952 | 225 | 20 | EFO_0007985 |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 5.79e-05 | 2 | 225 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | NCOA3 ETV3 DAG1 ARID1A TNFRSF21 RXRA PYHIN1 KMT2C RPRD2 ICAM1 SETD2 KMT2D ROBO2 ZFHX3 SPEN | 8.56e-05 | 616 | 225 | 15 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA3 ETV3 DAG1 ARID1A TNFRSF21 RXRA PYHIN1 KMT2C RPRD2 ICAM1 SETD2 KMT2D ROBO2 ZFHX3 SPEN | 8.56e-05 | 616 | 225 | 15 | C0376358 |
| Disease | cholesterol to total lipids in IDL percentage | 9.57e-05 | 60 | 225 | 5 | EFO_0022233 | |
| Disease | Familial vesicoureteral reflux | 1.73e-04 | 3 | 225 | 2 | cv:C4706552 | |
| Disease | plexin-A1 measurement | 1.73e-04 | 3 | 225 | 2 | EFO_0801892 | |
| Disease | Familial vesicoureteral reflux | 1.73e-04 | 3 | 225 | 2 | C4706552 | |
| Disease | Vesicoureteral reflux | 1.73e-04 | 3 | 225 | 2 | cv:C0042580 | |
| Disease | Replication Error Phenotype | 1.86e-04 | 15 | 225 | 3 | C1721098 | |
| Disease | Microsatellite Instability | 1.86e-04 | 15 | 225 | 3 | C0920269 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.86e-04 | 69 | 225 | 5 | DOID:1682 (implicated_via_orthology) | |
| Disease | serum gamma-glutamyl transferase measurement | REPS1 STAG1 SRARP SERTAD2 ARID1A ARHGEF11 POM121 IKZF3 SGIP1 COBLL1 ICAM1 NLRP1 SPECC1L JMJD1C SETD2 SBNO1 PCIF1 MUC6 | 2.46e-04 | 914 | 225 | 18 | EFO_0004532 |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.59e-04 | 74 | 225 | 5 | EFO_0022280 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 3.31e-04 | 78 | 225 | 5 | EFO_0022187 | |
| Disease | Vesico-Ureteral Reflux | 3.44e-04 | 4 | 225 | 2 | C0042580 | |
| Disease | Macrostomia | 3.44e-04 | 4 | 225 | 2 | C0024433 | |
| Disease | tenascin-X measurement | 3.44e-04 | 4 | 225 | 2 | EFO_0802121 | |
| Disease | T-cell non-Hodgkin lymphoma (is_implicated_in) | 3.44e-04 | 4 | 225 | 2 | DOID:0081312 (is_implicated_in) | |
| Disease | event-related brain oscillation | 3.44e-04 | 4 | 225 | 2 | EFO_0004358 | |
| Disease | neutrophil count | BNC2 SLC6A17 MBNL1 BCORL1 ETV3 ARID1A CIC RPRD2 ARHGAP25 ZNF282 BICD2 SGIP1 TTC28 ARHGAP23 CBFA2T3 JMJD1C SETD2 SBNO1 MICAL2 LRP4 R3HDM1 TNXB NOS1AP | 3.94e-04 | 1382 | 225 | 23 | EFO_0004833 |
| Disease | waist-hip ratio | TSHZ2 DAG1 MGLL BIRC6 CDCA2 TRIM66 SSC5D NFIX BICD2 DPYD TTC28 ADAMTS2 RBL2 COBLL1 IQCN LCP2 RFX4 JMJD1C TDRD7 MEGF8 DOT1L | 4.90e-04 | 1226 | 225 | 21 | EFO_0004343 |
| Disease | age at menopause | 5.53e-04 | 302 | 225 | 9 | EFO_0004704 | |
| Disease | Liver carcinoma | ACLY CLTRN ARID1A CDCA2 KMT2C FOXM1 DPYD TROAP DTL E2F8 CCNB1 CSPG4 | 5.61e-04 | 507 | 225 | 12 | C2239176 |
| Disease | Malignant Cystosarcoma Phyllodes | 5.70e-04 | 5 | 225 | 2 | C0600066 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 5.70e-04 | 5 | 225 | 2 | DOID:3030 (is_marker_for) | |
| Disease | vesicoureteral reflux (is_implicated_in) | 5.70e-04 | 5 | 225 | 2 | DOID:9620 (is_implicated_in) | |
| Disease | Phyllodes Tumor | 5.70e-04 | 5 | 225 | 2 | C0010701 | |
| Disease | Klatskin's tumor (is_implicated_in) | 5.70e-04 | 5 | 225 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.76e-04 | 50 | 225 | 4 | EFO_0022247 | |
| Disease | triglycerides to total lipids in large LDL percentage | 6.21e-04 | 51 | 225 | 4 | EFO_0022331 | |
| Disease | Intrahepatic Cholangiocarcinoma | 7.87e-04 | 24 | 225 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 7.87e-04 | 24 | 225 | 3 | C3805278 | |
| Disease | stroke | 8.55e-04 | 144 | 225 | 6 | EFO_0000712 | |
| Disease | triglycerides in large VLDL measurement | 8.86e-04 | 56 | 225 | 4 | EFO_0022178 | |
| Disease | triglycerides in very large VLDL measurement | 8.86e-04 | 56 | 225 | 4 | EFO_0022325 | |
| Disease | smoking cessation | 9.29e-04 | 325 | 225 | 9 | EFO_0004319 | |
| Disease | Breast Carcinoma | NCOA3 CTU2 LRRC37A2 TNIP1 ARID1A LRRC37A MMP14 FOXP3 FOXM1 DPYD SETD2 KMT2D | 9.39e-04 | 538 | 225 | 12 | C0678222 |
| Disease | systemic scleroderma, systemic lupus erythematosus | 9.99e-04 | 26 | 225 | 3 | EFO_0000717, MONDO_0007915 | |
| Disease | Cholangiocarcinoma | 9.99e-04 | 26 | 225 | 3 | C0206698 | |
| Disease | triglycerides in VLDL measurement | 1.08e-03 | 59 | 225 | 4 | EFO_0022326 | |
| Disease | Sezary Syndrome | 1.12e-03 | 27 | 225 | 3 | C0036920 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 1.15e-03 | 60 | 225 | 4 | C4722327 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.18e-03 | 103 | 225 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | suntan | 1.18e-03 | 103 | 225 | 5 | EFO_0004279 | |
| Disease | triglycerides in small VLDL measurement | 1.22e-03 | 61 | 225 | 4 | EFO_0022145 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.22e-03 | 61 | 225 | 4 | C1961102 | |
| Disease | monocyte count | STAG1 SERTAD2 ETV3 AHDC1 CIC NFIX ARHGAP25 NPAT DXO GPBAR1 CRYBG2 ARHGAP23 CARMIL1 ICAM1 SH3GL1 DIDO1 IQCN SETD2 IK NOS1AP MYBPC1 | 1.24e-03 | 1320 | 225 | 21 | EFO_0005091 |
| Disease | phospholipids in large VLDL measurement | 1.30e-03 | 62 | 225 | 4 | EFO_0022169 | |
| Disease | total lipids in very large VLDL measurement | 1.30e-03 | 62 | 225 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 1.30e-03 | 62 | 225 | 4 | EFO_0022299 | |
| Disease | neuroticism measurement, cognitive function measurement | STAG1 ARID1A BIRC6 SQOR NFIX NAV1 DXO RBL2 JMJD1C SH3D21 KIAA1217 ZFHX3 | 1.44e-03 | 566 | 225 | 12 | EFO_0007660, EFO_0008354 |
| Disease | cholesterol in large VLDL measurement | 1.55e-03 | 65 | 225 | 4 | EFO_0021902 | |
| Disease | Embryonal Rhabdomyosarcoma | 1.57e-03 | 8 | 225 | 2 | C0206656 | |
| Disease | breast carcinoma (is_marker_for) | 1.64e-03 | 66 | 225 | 4 | DOID:3459 (is_marker_for) | |
| Disease | total lipids in large VLDL | 1.73e-03 | 67 | 225 | 4 | EFO_0022175 | |
| Disease | triglycerides to phosphoglycerides ratio | 1.83e-03 | 68 | 225 | 4 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 1.83e-03 | 68 | 225 | 4 | EFO_0022265 | |
| Disease | Prostate cancer, familial | 1.93e-03 | 69 | 225 | 4 | C2931456 | |
| Disease | intraocular pressure measurement | STAG1 RXRA PLEKHA7 MXRA5 ANPEP ADAMTS2 CSPG4 PTCH2 LRP4 ZFHX3 TNXB | 1.95e-03 | 509 | 225 | 11 | EFO_0004695 |
| Disease | Liver Diseases, Parasitic | 2.01e-03 | 9 | 225 | 2 | C0023897 | |
| Disease | interleukin 18 receptor accessory protein measurement | 2.01e-03 | 9 | 225 | 2 | EFO_0008179 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.01e-03 | 9 | 225 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | Glaucoma | 2.01e-03 | 9 | 225 | 2 | C0017601 | |
| Disease | Leukemia, Myelocytic, Acute | 2.18e-03 | 173 | 225 | 6 | C0023467 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 2.20e-03 | 34 | 225 | 3 | EFO_0004458, EFO_0004612 | |
| Disease | bilirubin measurement | STAG1 SERTAD2 MGLL ARID1A BIRC6 RXRA SHKBP1 CARMIL1 REV3L JMJD1C | 2.22e-03 | 442 | 225 | 10 | EFO_0004570 |
| Disease | triglycerides to total lipids in small HDL percentage | 2.26e-03 | 72 | 225 | 4 | EFO_0022336 | |
| Disease | apolipoprotein A 1 measurement | REPS1 STAG1 TSHZ2 MBNL1 ARID1A MUC17 FOXK1 COBLL1 RFX4 JMJD1C CEP164 SBNO1 PCIF1 MACF1 R3HDM1 | 2.30e-03 | 848 | 225 | 15 | EFO_0004614 |
| Disease | free androgen index | 2.43e-03 | 374 | 225 | 9 | EFO_0007005 | |
| Disease | Mammary Carcinoma, Human | NCOA3 CTU2 LRRC37A2 TNIP1 LRRC37A MMP14 FOXP3 FOXM1 DPYD SETD2 KMT2D | 2.47e-03 | 525 | 225 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | NCOA3 CTU2 LRRC37A2 TNIP1 LRRC37A MMP14 FOXP3 FOXM1 DPYD SETD2 KMT2D | 2.47e-03 | 525 | 225 | 11 | C1257931 |
| Disease | Mammary Neoplasms | NCOA3 CTU2 LRRC37A2 TNIP1 LRRC37A MMP14 FOXP3 FOXM1 DPYD SETD2 KMT2D | 2.54e-03 | 527 | 225 | 11 | C1458155 |
| Disease | cervical cancer (is_marker_for) | 2.59e-03 | 36 | 225 | 3 | DOID:4362 (is_marker_for) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.73e-03 | 243 | 225 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | mucocutaneous lymph node syndrome | 2.75e-03 | 76 | 225 | 4 | EFO_0004246 | |
| Disease | Acute Myeloid Leukemia, M1 | 2.76e-03 | 125 | 225 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.76e-03 | 125 | 225 | 5 | C1879321 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.95e-03 | 127 | 225 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 3.04e-03 | 11 | 225 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | bone density | 3.10e-03 | 388 | 225 | 9 | EFO_0003923 | |
| Disease | aortic measurement | 3.26e-03 | 251 | 225 | 7 | EFO_0020865 | |
| Disease | Asthma | 3.31e-03 | 80 | 225 | 4 | C0004096 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 3.31e-03 | 80 | 225 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | sleep apnea | 3.51e-03 | 40 | 225 | 3 | EFO_0003877 | |
| Disease | very low density lipoprotein particle size measurement | 3.60e-03 | 133 | 225 | 5 | EFO_0008594 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.63e-03 | 12 | 225 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | fructose measurement, glucose measurement, galactose measurement | 3.63e-03 | 12 | 225 | 2 | EFO_0004468, EFO_0010477, EFO_0010481 | |
| Disease | mitochondrial DNA measurement | 3.85e-03 | 328 | 225 | 8 | EFO_0006312 | |
| Disease | oral microbiome measurement | 4.03e-03 | 42 | 225 | 3 | EFO_0801229 | |
| Disease | visceral adipose tissue measurement | BNC2 SERTAD2 CDCA2 TRIM66 CRYBG1 ANKS1A DPYD CARMIL1 IQCN ROBO2 | 4.05e-03 | 481 | 225 | 10 | EFO_0004765 |
| Disease | skin pigmentation measurement | 4.08e-03 | 137 | 225 | 5 | EFO_0007009 | |
| Disease | Autism Spectrum Disorders | 4.12e-03 | 85 | 225 | 4 | C1510586 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 4.31e-03 | 43 | 225 | 3 | DOID:9261 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ILSEPGPTLAPMPTV | 441 | Q8N6Y0 | |
| MAKVPAESPTLPPTF | 421 | Q03989 | |
| SDVIPPTPKTTPLFM | 1691 | Q9NR09 | |
| PTPKTTPLFMTPPLT | 1696 | Q9NR09 | |
| PPIKSAVQTMSPIPA | 4141 | Q9NR09 | |
| SSLPSPLSDPRREPM | 611 | Q8TD16 | |
| SPPLPMSLAVDILPS | 1926 | Q6UVK1 | |
| KEPPFPLSTRSIMEP | 166 | P46952 | |
| EISTPKTSPPPTSQM | 1846 | Q8IZF6 | |
| LLTPGEMVSPPTSLP | 576 | Q6ZN30 | |
| EMVSPPTSLPTSPII | 581 | Q6ZN30 | |
| LSDPSVLQLTPSLPM | 281 | Q6PIY5 | |
| APVTTPTMASIPPRI | 366 | P41162 | |
| PTMASIPPRIKVEPA | 371 | P41162 | |
| TPPMPVLTPVHTSSK | 641 | Q5H9F3 | |
| TRSLENPTPPFTPKM | 661 | O15085 | |
| AIPRTPLSPSPMKTP | 861 | Q69YQ0 | |
| DTPSTLPMLAVPQIP | 466 | Q9ULD4 | |
| MEPASPAPTPTSLRA | 486 | Q96C12 | |
| IRNPSLPPPEKMSEA | 171 | Q12882 | |
| LSNMLPKGPSTPLPE | 246 | P15144 | |
| SSVPSKPPMSLEPQN | 221 | Q6AI12 | |
| DKTPPPQPPLISSMD | 316 | Q92625 | |
| PRDASSSMLDLPKPP | 271 | Q6P656 | |
| SSPPITPPASETKIM | 511 | Q9NZJ0 | |
| GSMKLSPQDPRPLSP | 821 | Q8TEK3 | |
| KLVPPPSAMARSPTT | 946 | Q5TGY3 | |
| PSPTTPQPLRAQKEM | 971 | Q9Y4F5 | |
| PPLPPSTFQAKEMTS | 521 | Q05D60 | |
| LSPLSKMPHSVPQPL | 916 | Q53SF7 | |
| STEMPLAPPLTPDLS | 1191 | P58397 | |
| PTLPVPTVAMEVRPS | 1121 | O95450 | |
| PTVAMEVRPSPSTPL | 1126 | O95450 | |
| SPLPPRLSSSPGKTM | 801 | Q07912 | |
| PSPTPPDLEAMASLL | 91 | Q9Y2D1 | |
| SNVLMTLTPVSLPPP | 341 | Q9UKD1 | |
| TKMPPQPRTTSRPSV | 291 | P50281 | |
| LKTVRPSGPPLSIMP | 901 | Q15032 | |
| IPIPIPMPQSSESKF | 246 | Q9Y5P3 | |
| TKMSSPSPPVLDPYL | 371 | Q9UPQ7 | |
| EPCLMSSTPRLHPTP | 656 | Q33E94 | |
| PSPQTRLPAMITKTP | 491 | Q9H0B3 | |
| MAPPSEETPLIPQRS | 1 | P52333 | |
| LDTPTPMVPTSRVPG | 181 | Q9BRQ5 | |
| PSPLEPVISTMPSQT | 206 | Q96SU4 | |
| PVISTMPSQTVLPPE | 211 | Q96SU4 | |
| TSKVMVPPVTPDLPA | 1301 | Q14207 | |
| SPVMRSSSTLPVPQP | 966 | Q08999 | |
| REVEPMLPPSSSEPI | 851 | Q96PE2 | |
| LPRPMENRTSPSKSP | 1591 | O14497 | |
| VIRVQPPSPLPSSMD | 2686 | Q01484 | |
| HSMPTGTIPPPTTLK | 1646 | Q6W4X9 | |
| SMPTGTIPPPTTIKA | 1871 | Q6W4X9 | |
| TMPSPAPEVPLKTVG | 1096 | P52948 | |
| MELKPTAPPIFTGRP | 21 | Q12891 | |
| VELSPTMKETPTQPP | 561 | O60309 | |
| SMPLTEAPAFILPPR | 26 | Q15746 | |
| RPVPLPMPDSKSTST | 441 | Q14938 | |
| IPSLPQSPMRETPSK | 4261 | Q8NEZ4 | |
| MTILQAPTPAPSTIP | 11 | P46695 | |
| VAPLPMTPVPGRASK | 491 | Q8TC57 | |
| PSRVKATPMPSRPST | 886 | P27816 | |
| VELSPTMKETPTQPP | 561 | A6NM11 | |
| VELSPTMKETPTQPP | 561 | A6NMS7 | |
| LSTSTMSLPKPTEPP | 166 | Q96T17 | |
| VVKPTPAMLTTPSPS | 396 | O60721 | |
| HPLESPAMISLTPPT | 121 | Q9BZS1 | |
| PSSPTPESPTMLTKK | 141 | Q9NQS7 | |
| LMSTEPLPRTLSPTP | 186 | Q9NQS7 | |
| GPVLPTPTKTSTIPM | 1811 | Q2M2H8 | |
| MPEESSPRRTPQSIP | 1 | Q99685 | |
| LPPKPQSPTLMDTAS | 386 | O95665 | |
| MKPPTATPTTARTRP | 636 | Q8N307 | |
| KPVTSAPRPSMAPTS | 2641 | Q9UKN7 | |
| MAPTSALPSRSLEPP | 2651 | Q9UKN7 | |
| MTPNSTGEVPSPIPK | 1 | Q8TDU6 | |
| MAASCPLPVTPDLPT | 1 | Q8N6Q8 | |
| SLSPPTLTPVMPVNA | 1226 | Q15652 | |
| IPPSASLNLPPVTMS | 3041 | Q2LD37 | |
| DSKPPPSSSMPLILQ | 806 | Q14118 | |
| PPSLPSVPLLESLVM | 471 | Q5VYM1 | |
| AMTPRPTKARAPLPS | 46 | Q86SG4 | |
| RPPSTKEETSRPPMP | 1056 | Q5SYE7 | |
| EVKIQSRSSPPTMPP | 36 | O43439 | |
| TSDTPPPPADVLMTQ | 371 | P98177 | |
| KPGDLMPATTLIPPA | 1351 | Q9C000 | |
| MPATTLIPPARIAVP | 1356 | Q9C000 | |
| PTLTVMDISPPSRSP | 336 | Q9Y2U5 | |
| LLNVSPMPVESSPPL | 2041 | Q7Z7M0 | |
| PVPSVSAPNIAMKPS | 561 | P35658 | |
| SPVPPPRLKAMTSQA | 111 | Q71F78 | |
| KPTALPMVPPTSDRS | 1366 | Q6ZVL6 | |
| MLPVQPAELTPRSTP | 401 | A4D2B8 | |
| MVPREPQASPSTLPL | 61 | Q86UU5 | |
| STLPLTLERPSPVMP | 71 | Q86UU5 | |
| STVAQPSEMPPSPLV | 511 | Q9UBE8 | |
| PAEVKTQPRSTPPSM | 66 | O75081 | |
| QMAKPPSLAPPAVTS | 281 | A6NDN3 | |
| GSELLPMISPRSPSP | 331 | Q8IZ21 | |
| AMTQDLPSPPKTPSP | 381 | O77932 | |
| APVRPTSTTKPMPAP | 261 | O95274 | |
| KSLSQPTPPPMPILS | 6966 | Q9UPN3 | |
| PTPPPMPILSQSEAK | 6971 | Q9UPN3 | |
| LPMPSGKPQPTTSRT | 631 | Q5XG87 | |
| MASPAASSVRPPRPK | 1 | Q9H875 | |
| PPTTLLGLIPAPSMV | 241 | A6NF01 | |
| VAPSIPPVMSRPVSS | 1571 | Q14686 | |
| PPAPTLLKMTSSPVG | 1881 | Q14686 | |
| KPPTTLLGLIPAPSM | 656 | Q96HA1 | |
| TSPPASAPRTAMRLP | 96 | Q8IV32 | |
| SPEPILVDTASPSPM | 116 | P14635 | |
| APIPESPPSKSRSMS | 261 | Q8WWV6 | |
| TLMPVPISPPFTQRA | 1471 | Q6WRI0 | |
| EMESIPSPVAPLPTR | 561 | Q14721 | |
| SSPPPEKAPMVNRST | 196 | Q8WV28 | |
| VPSSPSIPGTPTLKM | 141 | Q9H4Z3 | |
| PVRLAVSAPPMPSVE | 406 | Q9H4Z3 | |
| APLAPLASMPSSVPK | 166 | A6NFR6 | |
| MVPLIPSPLSSAVPL | 496 | A0AVK6 | |
| LAISPISPVAAMPPL | 6 | Q9Y603 | |
| TATLPQRTLAMPAPP | 1966 | Q8TD84 | |
| MDTQPDRKPSRIPTP | 636 | Q99501 | |
| PVDPPAATVLPMVRS | 396 | Q8N1P7 | |
| LPESHLKTPQMPPTT | 431 | Q6K0P9 | |
| SPSRLKSPSMAVPSP | 991 | Q86UU0 | |
| VSDALMSPPPKSSLP | 1516 | Q9BTC0 | |
| LEVVTMPSPSPKGLP | 81 | Q96DP5 | |
| EPDLRSMVSPVPSPT | 231 | P85037 | |
| AQPVIMAVPPRPSSL | 476 | P85037 | |
| MAVPPRPSSLVAKPV | 481 | P85037 | |
| PSPKPTPSSDMTVRK | 526 | Q9ULH1 | |
| SPSLVPAEILPTAPM | 141 | Q9NR56 | |
| SVLGEPLPMPFTPTL | 921 | Q6UXX5 | |
| LPEVPEMTPSIPSIR | 596 | Q69YH5 | |
| LMDLSTTPLQSAPPL | 656 | Q08050 | |
| PAPQATSVKLPTPMQ | 776 | Q9P2N6 | |
| ERPPTILMTEEPSSP | 1081 | Q5VZK9 | |
| MAPSSPRPALPALLV | 1 | P05362 | |
| TKRKVVPPSPMTDPT | 91 | Q9P0I2 | |
| PTTVDTKDLPPTAMP | 431 | Q9Y4K1 | |
| SPRMLLPSSSSKPPG | 266 | O75052 | |
| RPLVQTPPAPTSEMV | 321 | Q9UKT9 | |
| ARPPLIPVTSMLFPV | 276 | Q96HA4 | |
| MTVPTLPSTAIPQPP | 886 | Q9NZ56 | |
| VTMTATPPLPKPVNT | 421 | Q5VT52 | |
| SEPSKLELPMPGTPI | 4146 | Q9NZJ4 | |
| KSIVNLDSPMVSPPP | 1051 | A3KN83 | |
| SPMNPVSSSEDIKPP | 96 | P19793 | |
| EMPLLARPSPPVQSV | 851 | Q5VV67 | |
| QMQSPIPLTETRTPP | 416 | Q2VPK5 | |
| TMRPPAKPSTSKDPV | 91 | Q14562 | |
| TPVNKRTMSPPKDPS | 1256 | O94851 | |
| RTMSPPKDPSPSLPL | 1261 | O94851 | |
| LLCTSSLRPMPPSPS | 241 | E9PI22 | |
| LEPLGPETTLVSMSP | 236 | Q8N9Y4 | |
| SSRSPPAPRFPLMTK | 1616 | Q6ZRI0 | |
| MPTSTPREGRPPLTS | 1916 | Q685J3 | |
| TPTPPEVITLPMSTP | 3616 | Q685J3 | |
| PLPGVSTIPLTMKPS | 796 | Q9H195 | |
| PSSPPTTTAPMRVSK | 1086 | Q9NXL9 | |
| QSELPSPPALPMSLS | 976 | Q8NEY1 | |
| PPTDMPTPTTDKITQ | 6 | Q7L099 | |
| LDPPTPCPDSSMKIS | 116 | Q86SS6 | |
| RTSPSAPSGMEPPKL | 4526 | O75445 | |
| PPMSPPDVLKTSPVA | 296 | Q9Y6N5 | |
| MLLTPLAPAPTPERS | 146 | Q8NA92 | |
| LSPSPQTGKPSMRTP | 11 | Q96R06 | |
| APPSKSPSMPSLNQT | 396 | Q96D71 | |
| APSPNRGLVTPPMKT | 66 | Q8NEQ6 | |
| VPAPVPLMSLRTAPA | 2211 | Q9UQ35 | |
| SSPVKAPSVKRTPMP | 226 | A4FU49 | |
| TTPIPQMEARTLPPG | 2346 | A2VEC9 | |
| TDKLALPMSPSPLSP | 506 | O75509 | |
| MSPTVFLPLPSPQVL | 116 | P12757 | |
| PSLLMPLPGTKALPS | 496 | Q9UMZ2 | |
| TPELARCPSPTMSLP | 746 | Q8N3V7 | |
| NRMKEPSSPPPAPTS | 36 | Q9BRQ6 | |
| MSPPDTPSLSPQITR | 1071 | Q5QGS0 | |
| FLPRPVDPSKLPSMS | 186 | O43320 | |
| ATPPSQVPPTQLIMS | 391 | Q9H6K5 | |
| SPLATPPLSAMSPLQ | 451 | Q9H6K5 | |
| LIMPPLETQSSLAPP | 706 | Q9H6K5 | |
| VTTSMTVAIHPPPLP | 1156 | Q9Y6C5 | |
| VTRAASPSGPPPMKI | 436 | O75603 | |
| SSPPVKNISAFPMLP | 866 | Q9Y6Q9 | |
| SMLEVPRSISVPPSP | 556 | Q6IQ23 | |
| MLSALESTVPPSQPP | 621 | Q5T5P2 | |
| RMLDEKTPPSPSGQP | 176 | Q8TBC3 | |
| PAPITAPVMSLTPEL | 1016 | Q9NQW1 | |
| DITVPPLMIPTEASP | 451 | Q8NHU6 | |
| DPTMAPDPITTLNPT | 1156 | A1L4H1 | |
| SKPPIETNAMHTTPP | 691 | Q9NZP6 | |
| LLCTSSLRPMPPSPS | 241 | P0DMB1 | |
| KMPALPVQATAISPP | 26 | Q9H190 | |
| RSLSMPDTSEDIPPP | 876 | Q9UPX8 | |
| KPAMPQDSVPSPRSL | 471 | P53396 | |
| SMPAQLPPRDPKSTP | 1296 | Q9UPV0 | |
| LTTVPMPSRAVPPST | 251 | Q99941 | |
| ISEPPSAPISPRMNK | 416 | Q99941 | |
| PATPSKATRFLPMDP | 581 | Q96RK0 | |
| LKIPSTLAPPMDPSV | 126 | Q9HBJ8 | |
| AVPPPRRSSSIASMP | 11 | E7ERA6 | |
| PPPNKISSDMPVSLR | 626 | Q9BXT8 | |
| LTPRPSPSPMIESTP | 1696 | Q7KZ85 | |
| SSQVMDPPTARPTEP | 611 | Q15025 | |
| PAPATSLAPAPLITM | 2416 | O15417 | |
| SLAPAPLITMPATRP | 2421 | O15417 | |
| SSDKPIRTPSRSMPP | 291 | Q99961 | |
| IIRPSPSLLTMASSP | 291 | Q9UM82 | |
| SMGPVKIPNTVSTPL | 1976 | Q86UP3 | |
| KTHSTATMPPPINPI | 106 | Q9NZ09 | |
| MSLSSKVSLPPIPAV | 246 | Q9NZ09 | |
| SAVLTPRVPTLPKMG | 201 | P17040 | |
| FPSPVSVSMKPDLPV | 3431 | Q96T58 | |
| TPRTANILKPLMSPP | 1871 | O60673 | |
| PALVMALTTTPVPDP | 406 | A0A1B0GUW6 | |
| SQAMQPTAPTKLSPP | 146 | Q14140 | |
| NPSMESPKLTRPFPT | 231 | Q9BQI5 | |
| TMVPEPTSALPSDPR | 206 | Q9P227 | |
| HPSSTPNPLERPIKM | 36 | P42331 | |
| PLLMSEPKPRTSSPR | 241 | Q6GPH4 | |
| TTQAVPTMTPEPPIK | 3046 | P22105 | |
| VQPKTRFTPMPSTPR | 351 | Q12815 | |
| TTPPEPRPSASSMQR | 1861 | Q9H254 | |
| RTDTMIQTPGPLPAP | 1101 | Q8WVM7 | |
| TPLPPPVVMESAAAI | 246 | A0A0J9YWL9 | |
| PSPMSDPVRTQDISP | 606 | Q9HCK4 | |
| MTPRAAPTSAPPSKS | 41 | Q13123 | |
| QTLQMSSPPPVESKP | 111 | Q6BDI9 | |
| MPPTASLTRSPPRAS | 411 | A8MUU9 | |
| APKMPESTPVSTPVP | 536 | Q9UBS9 | |
| IPMTNSPLLDPLPSL | 466 | Q8IZJ1 | |
| TTPKPASSSRVPPMK | 806 | Q9NRE2 | |
| LVSPPSSQTSPMPKT | 591 | Q63HK5 | |
| KVLLPTPSMDPVCSP | 2186 | Q9BYW2 | |
| VAPISPGPLTPMREK | 281 | P11137 | |
| GLTKPTLPPSPLMAA | 446 | P85298 | |
| PNSPVKMTLIPSPNS | 2106 | Q96AY4 | |
| LLPTMTPDGLAVTPT | 121 | P26368 | |
| ILSKVPSEAPSPMPT | 676 | Q9H1V8 | |
| LTISPPTSPREEMPA | 1286 | Q5VWN6 | |
| ATPVPSVVLTRSPPM | 131 | Q15633 | |
| SVVLTRSPPMELQPP | 136 | Q15633 | |
| APQAVPSLLSAPPKM | 666 | O15016 | |
| PRPEAKTMPNSSTPT | 286 | Q92547 | |
| PPAAMIAKPSPRTIA | 371 | P0DJG4 | |
| TATPLSPLKPPRMDT | 116 | Q9H898 | |
| SPLKPPRMDTAPVVA | 121 | Q9H898 | |
| STSPEPSKIMLVEPP | 281 | P18583 | |
| SSLLSPSREPPKMNP | 406 | Q8WY91 | |
| TLVPPTVESSPERPM | 506 | O94842 | |
| SGPSDSLLMVKNPPP | 391 | Q9UDV7 | |
| PLASMSLPPPKASPE | 356 | Q9P2T0 | |
| SPKPNLMGLPSTTVP | 3146 | Q15911 | |
| LSPAKEPVQPGMPLT | 316 | Q9C0D4 | |
| EPPVLPVSRMASIPS | 461 | Q5R3F8 | |
| ESPMSPPPEVSRLSP | 641 | O14686 | |
| TFPSRSTKPSPMNPL | 341 | Q13094 | |
| PPAPRATGMSEKSPV | 1656 | O75096 | |
| MKRKASSPVPLPPVT | 286 | Q99538 | |
| TIPLPLHMSKPSIPS | 1671 | Q9NR99 | |
| GISKPSMPSRPFVPL | 701 | Q00872 |